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 PAIN, QUALITY OF LIFE, AND COPING IN PEDIATRIC SICKLE CELL DISEASE 
 
by 
 
CRYSTAL MARIE STACK LIM 
 
 
Under the Direction of Lindsey L. Cohen, Ph.D.  
 
ABSTRACT 
 
Introduction: Sickle cell disease (SCD) affects predominately African Americans and is one of 
the most prevalent diseases in the United States (Schecter, 1999). Research has not sufficiently 
examined whether pain associated with SCD impacts quality of life or whether coping impacts 
this relation. The purpose of this study was to examine the relation between pain and quality of 
life in children with SCD and to determine whether coping moderates the relation. A secondary 
aim was to examine associations between age and pain, quality of life, and coping. A final 
exploratory aim was to examine the relation between racial identity and study variables. 
Method: 104 children (M = 12.93 years, SD = 3.17 years) with SCD and their parents 
participated during a regularly scheduled SCD-related medical visit. Parents completed a 
demographic form. Children completed the Pediatric Pain Questionnaire (PPQ), the Pain Coping 
Questionnaire (PCQ), the Pediatric Quality of Life Inventory (PedsQL), Sickle Cell Disease 
Quality of Life (SCD-QoL), and the Multidimensional Inventory of Black Identity (MIBI). 
 Results: After controlling for site and gender, regression analyses revealed that pain (β = -0.37) 
and emotion-focused avoidance coping (β = -0.39) were significant predictors of overall generic 
quality of life (PedsQL Total Score), total R2  = 0.44, F (5, 93) = 13.88, p < 0.001. There was no 
significant pain x coping interactions found for overall generic quality of life. Child age was not 
associated with study variables. Exploratory analyses revealed the MIBI Centrality Scale was 
associated with PCQ Approach Coping, r (80) = -0.24, p < 0.05, and the MIBI Regard Scale was 
correlated with PCQ Problem-Focused Avoidance Coping, r (84) = 0.30, p < 0.01. 
Discussion: This study found that pain and emotion-focused avoidance coping were inversely 
associated with quality of life in children with SCD. Coping was not found to moderate the 
relation between pain and overall quality of life. The associations between racial identity and 
coping demonstrate the importance of further examining cultural factors in children with SCD. In 
addition, there continues to be a need for future research to focus on the psychosocial functioning 
of children with SCD. 
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 I would like to dedicate this work to children with sickle cell disease and their families, 
whose participation in and support of this research would not be possible. Their courage and 
strength is an inspiration to us all. 
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CHAPTER 1 
INTRODUCTION 
 Sickle cell disease (SCD) is one of the most common genetic diseases in the United 
States (Schecter, 1999), primarily found in people of African descent. SCD affects 
approximately 1 in 400 African Americans (Brown, Mulhern, & Simonian, 2002), and more than 
70,000 children and adults are living with the disease in the United States (Sickle Cell Disease 
Association of America [SCDAA], 2005). Currently, about 1,000 infants born in the United 
States are diagnosed with SCD each year (SCDAA, 2005). Despite the high prevalence of SCD, 
research with this population is relatively sparse compared with other chronic pediatric health 
conditions (Lemanek, Ranalli, Green, Biega, & Lupia, 2003). 
 SCD is a group of genetic disorders that is characterized by the presence of abnormal 
hemoglobin, specifically the protein hemoglobin S, in the red blood cells (Thompson & 
Gustafson, 1996). The most common types of SCD are sickle cell anemia (SS), sickle-
hemoglobin C disease (SC), sickle beta-plus thalassemia, and sickle beta-zero thalassemia 
(SCDAA, 2005). The presence of abnormal hemoglobin S results in the irregular synthesis of 
hemoglobin, which causes red blood cells to become rigid and crescent shaped (i.e., sickled). 
When large numbers of sickled red blood cells collect, they hinder blood flow, which results in 
vaso-occlusive pain episodes. In addition to pain episodes, decreased oxygenation and blood 
flow are associated with pulmonary and cardiac complications; strokes; infection; skeletal, 
growth, and puberty complications; and liver and kidney dysfunction. However, for pediatric 
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patients with SCD, the most common and debilitating symptom reported by children and their 
parents is pain (Lemanek et al., 2003). 
Pain 
 Pain associated with SCD is considered both acute and chronic. Vaso-occlusive acute 
pain episodes occur in children with SCD about five to seven times a year and may last from one 
to three days (Lemanek et al., 2003). These pain episodes are relatively unpredictable and vary in 
frequency and severity (Thompson & Gustafson, 1996). Treatment of acute pain episodes most 
often occurs at the patient’s home but may be severe enough to require hospitalization (Shapiro 
et al., 1995). The locations of acute pain episodes are also variable, although past research has 
indicated that the arms, legs, abdomen, chest, and back are the most common sites of pain 
reported by children with SCD and their parents (Graumlich et al., 2001; Lemanek et al., 2003; 
Schecter, 1999). Pain associated with SCD is described by children as aching, tiring, and 
uncomfortable (Walco & Dampier, 1990). Vaso-occlusive episodes are thought to be triggered 
by various environmental and psychological states, such as high altitudes, extreme temperatures, 
infection, dehydration, stress, and fatigue (Schecter, 1999). Painful episodes experienced by 
children with SCD often interfere with academic functioning, such as attending school and 
completing homework; social activities, such as participating in activities with family members 
and peers; and the quality and quantity of sleep (Gil et al., 2000; Shapiro et al., 1995). 
Besides acute pain episodes, SCD is also associated with chronic pain. Chronic pain due 
to SCD is more common in adults than in children and more common in adolescents than in 
young children (Schecter, 1999); however, chronic pain in pediatric SCD has only been recently 
discussed on a limited basis. Aseptic necrosis, or bone death due to poor blood oxygenation, is 
thought to cause chronic pain in limbs and joints (Ballas, 1998; Schecter, 1999). In addition, 
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shrinking of the vertebrae is thought to be the source of chronic back pain in children with SCD. 
Another source of chronic pain associated with the disease is poor circulation, which can lead to 
leg ulcers. As chronic pain increases in frequency and severity, a cycle of inadequate coping 
skills, poor relationships, and worsening pain may develop in children with SCD (Shapiro, 
1993). Thus, there is a need for researchers to better understand the influence of acute and 
chronic pain on the health and functioning of children with SCD, as well as to identify possible 
correlates and predictors of health and functioning (Palermo, Schwartz, Drotar, & McGowan, 
2002). 
 Developmental issues. Understanding how developmental factors interact with pain in 
children with SCD is important. In healthy children, there is evidence to suggest that symptoms 
of recurrent pain increase as children get older (Petersen, Brulin, & Bergstrom, 2006). 
Mechanisms through which this may occur could be related to increased exposure and 
sensitization to painful experiences or a decreasing ability to manage pain due to a variety of 
developmental factors. However, little is known about how developmental factors may relate to 
acute and chronic pain in children with chronic medical conditions, such as SCD. 
Given that SCD is a progressive chronic illness, it is likely that children with SCD 
experience an increase in acute and chronic pain symptoms as they progress through childhood 
and adolescence. However, there is limited empirical information about how age is related to 
acute and chronic pain in this population. Therefore, there is a need for researchers to examine 
how acute and chronic pain is experienced across developmental stages. 
Quality of Life 
Significant advances in the diagnosis and treatment of SCD have led to increases in the 
life span of patients. Compared to the early 1970s, when median life expectancy for patients with 
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SCD was about 14 years of age, life expectancy in the 1990s was about 45 years of age (Platt et 
al., 1994). Much of the increase in life expectancy can be attributed to advances in medical 
treatments for SCD (Eiser & Morse, 2001). Such increases in life expectancy and the 
development of new treatments have prompted researchers to focus on ways to measure and 
improve the quality of life of patients with SCD.  
Quality of life is important to measure in children with SCD for three main reasons. First, 
it can be used to describe the health profile and functional status of children living with the 
disease (Palermo et al., 2002). There is a lack of descriptive studies in the literature about quality 
of life in children and adults with SCD, as well the effects of pain on patients with SCD 
(Shapiro, 1993). Thus, a study on quality of life in this population could add important 
information about the impact of the illness. Second, information about this construct can be 
helpful when evaluating the effects of new medical procedures (i.e., transfusion therapy, bone 
marrow transplants) or the impact of new medications on the daily functioning of children with 
SCD (Palermo et al., 2002; Stegenga, Ward-Smith, Hinds, Routhieaux, & Woods, 2004). For 
example, physicians may prescribe one medication over another due to the impact of potential 
side effects on a pediatric patient’s quality of life. Third, information about quality of life can be 
utilized by physicians and psychologists to evaluate the needs of children with SCD and their 
families. Interventions can then be implemented to target areas of functioning where there is 
decreased quality of life (Palermo et al., 2002). Despite the importance of assessing quality of 
life in patients with SCD, there is a paucity of research examining quality of life in children with 
SCD. 
Quality of life has been widely accepted as a multi-dimensional, patient-centered 
construct that includes several domains, such as physical functioning and symptoms, 
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psychological and emotional states, social functioning, the performance of daily activities, and 
disease-related symptoms (Coons & Kaplan, 1992; Panepinto, O’Mahar, DeBaun, Loberiza, & 
Scott, 2005; Quittner, 1998). Quality of life in adults and children with SCD has been previously 
examined, although the amount of work in this area is limited. 
Qualitative work with adolescents and adults with SCD provides information about the 
disease’s impact on areas of quality of life. Thomas and Taylor (2002) conducted focus groups 
with patients with SCD ranging in age from 15 to 35. All patients who attended the focus groups 
(n = 17) identified six areas where they felt SCD impacted their quality of life. These areas 
included: growing up with SCD, education, the recurrent nature of the disease, employment, 
relationships, and hospitalization.  
Stegenga et al. (2004) also qualitatively examined quality of life in 10 children, ages 6 to 
12, with SCD who were receiving transfusion therapy for stroke. Transfusion therapy has been 
shown to reduce the amount of HbS in the blood, which improves blood flow and reduces the 
risk of additional strokes. However, transfusions are rigorous and time intensive for children and 
their families (Stegenga et al., 2004). Results of the study revealed five themes that emerged as 
concerns across participants. These included pain (physical and psychological), school issues 
(i.e., attendance and being treated differently by teachers and peers), disease knowledge, 
transfusion therapy, and having a stroke. However, it is important to note that children in the 
study did not discriminate between quality of life related to transfusion therapy and quality of 
life related to the impact of having SCD. In addition, a small sample size with a limited age 
range was utilized, so these findings may not be applicable to older children, those who have not 
experienced a stroke, or those who have not received transfusion therapy. In addition to these 
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qualitative studies, some researchers have used quantitative quality of life measures to examine 
the construct in adults and children with the SCD. 
Quality of life has traditionally been measured in two ways: a) generic measures, and b) 
disease-specific measures. These measures are completed by the patient, or by a proxy 
respondent (e.g., parent) in the case of younger children. The advantages and disadvantages of 
these types of quality of life measure will be discussed. 
Generic measures. Generic quality of life measures, or health profiles, are instruments 
designed for application across a wide range of diseases, necessitating items that are general and 
applicable to a variety of diseases. Examples of generic measures used with adolescent and adult 
SCD populations include the Short-Form Health Survey (SF-36) (Ware & Sherbourne, 1992), the 
Child Health Questionnaire (CHQ) (Landgraf, Abetz, & Ware, 1996), and the Pediatric Quality 
of Life Inventory (PedsQL) (Varni, Seid, & Kurtin, 2001). The benefits of using generic quality 
of life instruments include their assessment of multiple domains of functioning and their ability 
to compare quality of life scores across diseases (Quittner, Davis, & Modi, 2003). 
Some research examining quality of life in adults with SCD has utilized generic measures 
to examine differences between patients with SCD and healthy samples. In the United Kingdom, 
Anie, Steptoe, and Bevan (2002) found that adults with SCD reported significantly poorer 
quality of life when compared to the general population on all subscales on the SF-36. However, 
it is not clear what the racial or ethnic make-up was of the healthy comparison sample. It is 
possible that some factors resulting in poorer quality of life in the SCD sample could be the 
result of potential cultural or socioeconomic differences that were not accounted for. 
A more recent study conducted in the United States by McClish et al. (2005) found that 
patients with SCD between the ages of 16 and 64 had significantly poorer quality of life across 
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all domains of the SF-36 when compared to national norms for healthy adults, with the exception 
of the mental health subscale, which assesses symptoms of anxiety and depression. However, the 
racial and socioeconomic characteristics of the comparison group are not clear. Taken together, 
past quantitative and qualitative studies demonstrate that in children and adults, SCD has a 
significant impact on quality of life. 
One study by Palermo et al. (2002) compared quality of life in children, ages 5 to 18, 
with SCD to the quality of life of healthy controls on the CHQ. Results from this study revealed 
that children with SCD have poorer physical, psychological, and social functioning compared to 
healthy African American children. In addition, this study assessed SCD related complications 
and found that the number of disease-related complications was associated with decreased 
quality of life. To measure disease complications, a review of the patient’s medical chart was 
utilized over a two year period. Given that children with SCD are most often treated at home for 
painful episodes (Conner-Warren, 1996; Shapiro et al., 1995), the generalizability of these 
findings are limited to more severe disease complications (e.g., hospitalizations, stroke). 
Examining these relations in different SCD-related complications, such as vaso-occlusive acute 
pain episodes and chronic pain, is warranted. 
Another study (Barakat, Lutz, Nicolaou, & Lash, 2005) examined quality of life in 
children, newborn to 11 years of age, with SCD hospitalized for pain or fever by utilizing the 
Miami Pediatric Quality of Life Questionnaire (MPQOL). When compared to a clinic sample of 
children with leukemia, children with SCD had significantly lower total quality of life, social 
competence, and self-competence. However, they had significantly higher emotional stability. 
This study also calls into question the use of the comparison group who likely differed from 
children with SCD on racial and socioeconomic characteristics. In addition, both the Palermo et 
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al. (2002) and Barakat et al. (2005) studies utilized parent-proxy reports of quality of life. 
Research with SCD and other pediatric populations suggest that children and parents offer 
unique perspectives about the impact chronic illnesses may have on quality of life (Eiser & 
Morse, 2001; Panepinto et al., 2005). For example, Panepinto et al. (2005) found that parents of 
children with SCD rated their child’s quality of life lower in most domains examined (with the 
exception of mental health and family activities) on the CHQ when compared to children’s 
report. Thus, child report of quality of life offers unique information about their every day 
functioning and continuing to examine it in children with SCD is needed. 
Generic quality of life measures have been criticized for their inability to assess relevant 
domains of functioning for specific diseases. For example, a generic measure such as the SF-36 
does not assess specific symptoms associated with SCD, such as disease-related pain. In 
addition, generic measures also tend to be less sensitive to small, but meaningful changes that 
occur as a result of clinical interventions (Juniper et al., 1996). Finally, most generic measures 
have not been validated with specific disease populations, but instead have been normed 
primarily on healthy populations, limiting their reliability and validity for use in chronic disease 
populations (Abbott, Webb, & Dodd, 1997; Quittner et al., 2003). To reduce these problems and 
to provide more sensitive, comprehensive evaluations of quality of life, researchers have recently 
developed disease-specific measures that include core quality of life dimensions (e.g., physical 
functioning, social functioning), as well as disease-specific dimensions (e.g., pain). 
Disease-specific measures. Over the past decade, disease-specific measures have been 
developed in order to detect and quantify changes in quality of life in patients with particular 
diseases. For example, disease-specific measures have been developed for children with diabetes 
(Diabetes Quality of Life for Youths; Ingersoll & Marero, 1991) and asthma (Paediatric Asthma 
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Quality of Life Questionnaire; Juniper et al., 1996). The advantages of using disease-specific 
quality of life measures include the information they provide about specific domains of 
functioning and their greater sensitivity to the effects of interventions for target populations 
(Juniper et al., 1996). The major disadvantage of using disease-specific measures is that they do 
not allow for comparisons across different diseases (Quittner et al., 2003). Currently, no disease-
specific quality of life measure has been developed for adults or children with SCD. In the 
current study, both a generic and a new disease-specific measure were utilized to evaluate quality 
of life in children with SCD. 
Developmental issues. When examining quality of life in children it is also important for 
researchers to recognize that development may play an important role. Given the positive 
relation between age and cognitive ability, it is possible that a similar relation might exist 
between age and perceptions of quality of life (Annett, 2001). Specifically, it is thought that due 
to their stable, self-focused cognitions younger children may not realize that their health may 
change over time, which may lead them to misperceive the cause of their illness (Quittner et al., 
2003). Thus, these cognitions and misperceptions may impact their report of their own quality of 
life. For example, due to egocentricism younger children may think that their physical limitations 
are due to something they did wrong while older children may perceive health related limitations 
due to their medical condition, as well as compare their functioning to that of other children. 
In children with SCD, there is some evidence to suggest that older age is related to 
decreased quality of life. Specifically, Palermo et al. (2002) found that age was inversely related 
to quality of life on the physical functioning domain of the CHQ; however this result was not 
found on the psychosocial functioning domain and the study relied on a parent proxy report of 
quality of life. It should be noted that this is the only study to date that has specifically examined 
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the impact of age on children’s report of quality of life in SCD. Clearly there is a need to better 
understand how children of different ages with SCD perceive their quality of life.  
Pain and Quality of Life 
Although pain and quality of life have been studied separately in patients with SCD, only 
two studies have examined both of these constructs in SCD. Anie, Steptoe, and Bevan (2002) 
found that higher pain was significantly related to four areas of quality of life in adult patients 
with SCD: poorer physical functioning, greater role limitations, lower social functioning, and 
more negative health perceptions. A study conducted by Fuggle, Shand, Gill, and Davies (1996) 
found that pain impacted quality of life in children with SCD more than it did in control children. 
In this study quality of life was measured via four questions related to an inability to perform 
everyday activities (e.g., did not go to school, school work not completed, missed sports, and 
missed favorite activities). This measure did not assess physical, social, or emotional 
functioning. Thus, this measure is not consistent with quality of life being defined as a 
multidimensional construct. Whether these findings apply to other areas of quality of life in 
children with SCD is unclear. Given that pain only accounts for a portion of the variance in 
quality of life and that pain can be challenging to treat in SCD, it is important to study factors 
that might influence the relation between pain and quality of life. 
Given the paucity of research on pain and quality of life and the lack of examination of 
moderators of this relation in pediatric SCD, studies of pain and quality of life in children 
without SCD might shed light on what moderators may be important to consider. Parental 
factors, such as parenting stress (Guntlett-Gilbert & Eccelston, 2007), parental response to pain 
(Peterson & Palermo, 2004), and parental attention to pain (Van Slyke & Walker, 2006) have 
been found to impact pain and functioning in children. Despite the importance of parents, 
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parental factors do not account for all of the variance in predicting children’s functioning. In 
addition, there is a need to study individual child factors in order to create and implement child-
focused interventions to improve quality of life in pediatric patients experiencing chronic pain. 
Some studies have focused on emotional symptoms and found that depression impacts both pain 
and every day functioning in children with chronic pain (Claar & Walker, 2006; Guntlett-Gilbert 
& Eccelston, 2007). Additional studies have found that coping impacts functioning (Kashikar-
Zuck et al., 2002); however, there is a need for researchers to continue to examine coping in 
children with chronic illnesses and there are few studies that focus on coping in children with 
SCD. 
Coping 
One concept that may be important to consider when examining pain and quality of life 
in children with SCD is coping. Coping is defined by Lazarus and Folkman (1984) as cognitive 
and behavioral efforts that constantly change in order to manage external and internal demands 
that are taxing or exceeding available resources. In addition, Compas et al. (2001) define coping 
as conscious, purposeful efforts to regulate emotion, cognition, behavior, physiology, and 
environment in response to stress. Coping has been linked to health status and is viewed as a 
central factor related to the well being of children with chronic illnesses (Compas, Worsham, & 
Ey, 1992). Folkman, Lazarus, Gruen, and DeLongis (1986) described three ways in which 
coping may influence health status. First, coping may influence the frequency, intensity, and 
pattern of physiological responses, such as neural firing that result from experiencing pain. 
Second, coping can affect health when it involves excessive use of dangerous substances or 
participation in dangerous situations. Third, certain forms of coping can impede adaptive health 
or illness-related behavior. In addition, studying coping in children who experience pain, such as 
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in SCD, is important because how children cope likely influences how they cope and adjust to 
pain as adults (Gil, Williams, Thompson, & Kinney, 1991). For these reasons, examining coping 
in children with SCD is warranted. 
A commonly used measure to examine coping in adults and children with SCD is the 
Coping Strategies Questionnaire for Sickle Cell Disease (CSQ-SCD), developed by Gil and 
colleagues (Gil, Abrams, Phillips, & Keefe, 1989; Gil et al., 1997; Gil et al., 1991). The measure 
has demonstrated good internal consistency in adults and children (Gil et al., 1989; Gil et al., 
1991) and consists of three factors: coping attempts, negative thinking, and passive adherence. 
Coping attempts refers to coping with pain actively by utilizing cognitive and behavioral 
strategies, such as distraction and increased activity (Anie, 2005). Negative thinking is related to 
engaging in negative thinking patterns, such as catastrophizing, fear and anger, and isolation. 
Passive adherence refers to utilizing coping strategies recommended by health care professionals 
to reduce pain, such as rest and fluid intake (Anie, 2005).  
In one of the first studies of coping in pediatric SCD, Gil et al. (1991) found that some 
coping strategies children and adolescents engage in are related to psychosocial and functional 
impairment. Specifically, children using more passive adherence strategies, such as rest and 
drinking fluids, had more emergency room visits and less activity while in pain, whereas children 
high on coping attempts, such as distraction and increased activity, had less frequent emergency 
room visits and were more active during painful events. In addition, children with high levels of 
negative thinking, such as fear and anxiety, were found to be less active and more 
psychologically distressed. However, in this study parents provided ratings of child pain but 
children reported on the coping strategies they utilize. It is possible that different results may 
have been discovered if children provided their own pain ratings. In fact, Barakat, Simon, 
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Schwartz, and Radcliffe (2008) found that pain ratings by adolescents with SCD and their 
parents were only moderately consistent. This finding indicates the importance of assessing 
coping and pain from the child’s perspective in pediatric research. 
Another study examined coping strategies in 8- to 17-year-old children with SCD during 
a laboratory pain task (e.g., cold pressor task; Gil et al., 1997). This study found that children 
who reported the use of more cognitive and behavioral pain coping strategies reported lower pain 
levels than those who reported the use of fewer coping strategies. However, pain in laboratory 
tasks is predictable, whereas acute pain associated with SCD is relatively unpredictable. In 
addition, the impact of laboratory pain and pain associated with a chronic illness are qualitatively 
and quantitatively different. Pain that is the result of a chronic illness has the potential to disrupt 
a child’s lifestyle (e.g., not attending school) and may cause emotional distress for the child and 
their family which may impact pain coping strategies. 
An additional study examining coping in children with SCD was conducted in the United 
Kingdom. Anie, Steptoe, Ball, Dick, and Samlling (2002) found that child report of passive 
adherence coping strategies was associated with more intense pain, which was reported by 
parents. However, it is unknown whether this relation would have been found if child report of 
pain was included. There is a need for future coping research to evaluate pain and coping from 
the perspective of children with the disease. 
The studies examining coping in children with SCD have utilized mostly the CSQ-SCD. 
However, there are some limitations to using the CSQ-SCD. One is that the measure is time 
intensive. The measure consists of 80 items, which may not be practical for use in clinical 
settings, such as during regularly scheduled SCD-related medical visits. Second, the CSQ was a 
measure originally created for use with adults experiencing pain. Thus, some of the items may 
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not be developmentally appropriate for children. Utilizing coping measures with fewer items and 
items that are developmentally appropriate for children is warranted. 
A third drawback to the CSQ-SCD is that it does not tap common coping constructs 
discussed and examined in the pediatric psychology literature, such as problem- and emotion-
focused coping (Folkman et al., 1986; Lazarus & Folkman, 1984) and approach and avoidance 
coping (Bernard, Cohen, McClellan, & MacLaren, 2004; Rudolph, Dennig, & Weisz, 1995). 
Lazarus and Folkman (1984) posited that coping consists of two main types: problem-focused 
and emotion-focused. Problem-focused coping refers to efforts made to change some aspect of 
the situation by eliminating or altering it. Emotion-focused coping is described as strategies that 
are used to regulate the negative emotions associated with the situation. Another common 
dimension of coping is approach and avoidance. Approach coping refers to efforts to focus on or 
confront a stressful event (e.g., vaso-occlusive SCD pain episode), whereas avoidance coping 
refers to attempts to avoid or ignore a stressful event (Bernard et al., 2004; Rudolph et al., 1995). 
Continuing to examine coping in children with SCD is recommended, but the use of additional 
coping measures might continue to shed light on how children with SCD handle pain associated 
with the disease. 
Developmental issues. Similar to pain and quality of life, the literature examining 
children’s coping has revealed important developmental patterns. In a review of the literature, 
Compas et al. (1992) found that specific types of coping, especially emotion-focused coping, 
increases as children get older. In children with SCD, Gil et al. (1991) found that passive 
adherence, which is associated with maladaptive adjustment, was positively correlated with child 
age. Therefore, as child age increased so did the use of a negative coping strategy. However, 
later studies have not found a significant relation between coping and children’s age in pediatric 
15 
SCD (Gil, Wilson, & Edens, 1997). Given the inconsistent findings between coping and age in 
children with SCD further research in this area is needed. 
Pain, Quality of Life, and Coping 
To date, only one study has examined pain, quality of life, and coping in children with 
SCD. Fuggle et al. (1996) found that SCD related pain impaired daily activities in children 6 to 
16 years of age when compared to healthy control children. In addition, the most common way 
children in the study coped with pain was by talking to parents. However, this study had 
numerous limitations. One was the lack of a multidimensional assessment of quality of life. 
Important areas of quality of life, such as emotional and social functioning, were not examined. 
Another limitation was that coping was assessed utilizing diaries in which children reported how 
they handled their pain. This strategy may have overlooked important coping strategies, such as 
problem- and emotion-focused strategies. A third limitation is that the relations among all three 
variables were not examined. For example, it is possible that coping might have moderated the 
relation between pain and quality of life, as has been found in a study of adolescents with non-
specific chronic pain (Merlijn et al., 2005).  
The purpose of the current study was to investigate relations among pain, quality of life, 
and coping in children with SCD. More specifically, this study sought to explore the potential 
moderating impact of coping styles on the relation between pain and quality of life (Specific Aim 
#1). Although previous studies have investigated pain in children and adolescents with SCD, 
limited information about quality of life is available in this population. In addition, there is 
limited research examining coping in children with SCD. Taking these factors into consideration, 
the results of this study will not only provide valuable information about pain, quality of life, and 
coping in children with SCD, but may help lay the necessary groundwork leading to the 
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development and implementation of theoretically derived interventions that have the potential to 
improve the lives of children with SCD and their families. 
It was hypothesized that coping would moderate the relation between pain and quality of 
life (See Figure 1). Specifically, coping would act as a protective factor in the relation between 
pain and quality of life, with children who experience high pain and utilize more approach 
coping strategies having higher quality of life compared to children with high pain who utilize 
less approach coping strategies. In addition, it is unclear how children’s age may influence pain, 
quality of life, and coping in children with SCD. Thus, this study will attempt to explore how age 
influences these constructs (Specific Aim #2). Cultural factors are also important to consider in 
research with children who have SCD. 
Cultural Factors 
SCD is a disease that affects primarily people of African descent, and there may be 
unique cultural factors relevant to the adjustment of patients with SCD (Barbarin & Christian, 
1999) that have been overlooked in prior research. Gurung (2006) stated, “The experience of 
illness is shaped by cultural factors that influence how it is perceived, labeled, and explained and 
how the experience is valued” (p. 297; italics added). Since SCD is a chronic medical condition 
that affects primarily a minority group (i.e., African Americans or those of African descent), 
examining cultural variables is important (Kaslow, Collins, Loundy, Brown, Hollins, & Eckman, 
1997; Kaslow et al., 2000) and unfortunately has been overlooked in most of the current body of 
pediatric psychology research. In fact, a recent review of empirically supported treatments in 
pediatric psychology found that 27% of pediatric studies included information about 
participants’ race or ethnicity, whereas even fewer (e.g., 6%) identified possible moderating 
cultural variables (Clay, Mordhorst, & Lehn, 2002). Thus, there is a need for researchers to 
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examine cultural variables in this pediatric population. In addition, examining cultural factors 
may prove valuable in understanding this population and the possible impacts cultural factors 
may have on children with SCD. 
Racial identity. One important cultural factor that has been defined in the literature is 
racial identity. Despite racial identity being what Sellers, Smith, Shelton, Rowley, and Chavous 
(1998) described as “one of the most heavily researched areas that focuses on the psychological 
experiences of African Americans” (pg. 19), it has been significantly understudied in adult and 
pediatric patients with SCD. 
Racial identity has been conceptualized as a person’s group or collective identity based 
on perceptions that they share a common heritage with a specific racial group (Chavez & Guido-
DiBrito, 1999; Helms, 1993). The Multidimensional Model of Racial Identity (MMRI; Sellers, 
Rowley, Chavous, Shelton, & Smith, 1997; Sellers et al., 1998) provides a framework for 
researchers to investigate the impact of racial identity on a variety of outcomes. 
The MMRI posits that racial identity in African Americans is the significance and 
meaning people place on their membership within the Black racial group that is incorporated into 
their self-concept (Sellers et al., 1998). Sellers and colleagues (1997, 1998) hypothesized that 
racial identity is composed of four dimensions: salience, centrality, regard, and ideology. 
Salience refers to how relevant one’s race is to one’s self-concept during a particular time or 
situation. Centrality is the degree to which race is an important component of a person’s self-
concept or identity. In MMRI, regard refers to positive or negative feelings about being Black. 
Ideology consists of beliefs, opinions, and attitudes about how members of the race should act. 
Aspects of the MMRI have been examined in adults with SCD. Bediako, Lavender, and Yasin 
(2007) found that one aspect of the model, racial centrality, was negatively associated with pain 
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severity ratings in adults 18 to 64 years old with SCD. These results suggest that patients who 
reported being Black as a large part of their self-concept also reported less severe pain episodes, 
which may indicate that positive racial identity may act as a buffer in patients with SCD. 
However, whether positive racial identity may be related to better pain outcomes in children with 
SCD is unknown. 
In fact, one study by Barbarin (1999) examined the impact of parent’s racial identity on 
the psychological functioning of children with SCD. Racial identity, where racial attributions 
were used to explain the condition of African Americans in the United States, was found to 
significantly predict children’s psychological functioning; specifically more positive racial 
identity in parents was related to better functioning in their children. However, very little 
research has focused on children’s racial identity. In addition, very little research has examined 
racial identity in the context of a pediatric chronic illness. This study examined the associations 
between racial identity and pain, quality of life, and coping in children with SCD and to date is 
the only study to do so. 
Pain. The perception and experience of pain has been recognized as being influenced by 
various social and cultural factors (Craig & Riddell, 2003; Gurung, 2006). The impact of cultural 
beliefs on the experience of pain has been recognized in cancer research with adults. 
Specifically, Lasch (2000) posits that cultural factors may influence the expression of pain, the 
language used to describe pain, the context of pain related suffering, social roles and 
expectations, holistic treatments for pain, and perceptions of the health care system. Despite the 
obvious potential importance of cultural factors on the pain experience related to SCD there is 
little mention of them in the SCD research focusing on adults. 
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The cultural experience of African Americans in the U.S. may also impact the frequency 
and intensity of pain related to SCD. Racism, “beliefs, attitudes, institutional arrangements, and 
acts that tend to denigrate individuals or groups because of phenotypic characteristics or ethnic 
group affiliation” (Clark, Anderson, Clark, & Williams, 1999, p. 805), is considered a significant 
stressor for African Americans and has been found to impact both psychological and 
physiological health (Clark et al., 1999). Given that acute pain episodes in SCD are thought to be 
in part triggered by psychological states (Schecter, 1999); it is possible that racism experienced 
by adults and children with SCD could exacerbate pain related symptoms.  
However, there is little mention of cultural factors as they relate to pain in children with 
SCD in the current literature. Thus, it is unclear what role cultural factors may play in the 
expression of both acute and chronic pain in children with SCD. There is a need for researchers 
to begin to incorporate cultural variables in pediatric research (Clay et al., 2002) and this study is 
one of the first to attempt to do so. 
 Quality of life. Similar to pain, little is known about how racial identity may impact 
quality of life in children with SCD. Research on this variable in adults is even lacking. 
However, Bediako et al. (2007) indicated that positive racial identity in African Americans may 
be health enhancing. Thus, it may be likely that positive racial identity would be positively 
correlated with quality of life. However, research is needed to examine whether this is true in 
children with SCD. 
Coping. How children with a chronic illness cope is likely influenced by various social 
and cultural factors. In addition, specific types of coping may be valued over others in specific 
cultures. In fact, research focusing on health behaviors in adults, such as mammogram screening 
(Kudadjie-Gyamfi & Magai, 2008) and prostate screening (Kudadjie-Gyamfi, Consedine, & 
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Magai, 2006), has revealed significant cultural differences in coping styles. In addition, some 
coping differences have been found between racial groups in adults with chronic pain. Two 
recent studies found that African Americans significantly differed from Caucasians on the use of 
praying/hoping as a coping strategy (Edwards, Moric, Husfeldt, Buvanendran, & Ivenkovich, 
2005; Tan, Jensen, Thornby, & Anderson, 2005). Another study also found that African 
Americans reported using diverting attention, prayer, and hoping pain coping strategies more 
often than Caucasians (Cano, Mayo, & Ventimiglia, 2006). However, in these studies these few 
coping strategies were the only significant differences found between racial groups. Given the 
amount of analyses conducted these results indicate few ethnic differences in pain coping 
strategies in adults experiencing chronic pain. However, the relation between racial identity and 
coping strategies have not been examined in children with chronic pain. It is likely that racial 
identity may be a key cultural factor that impacts how children with SCD cope with disease-
related pain. This project will be the first to explore the relation between racial identity and 
coping in children with SCD. 
Since there is limited information about racial identity in children with SCD, this aim was 
exploratory in nature. This was the first pediatric psychology study to examine the role of racial 
identity on pain, quality of life, and coping in children with SCD (Specific Aim #3). Including 
racial identity in this study is important, as it could lead to the identification of protective cultural 
factors which could be used to develop culturally appropriate interventions that reduce pain, 
increase quality of life, and improve coping in children with SCD. 
Specific Aims 
 Aim 1.  Examine coping as a moderator in the relation between pain and quality of life in 
children with SCD. 
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It was hypothesized that approach coping would moderate the relationship between pain 
and overall quality of life. 
Aim 2. Explore the relation between child age and pain, quality of life, and coping. 
It was expected that child age would be associated with pain, quality of life, and coping. 
Specifically, that as child age increases pain increases, quality of life decreases, and approach 
coping increases. 
Aim 3. Conduct exploratory analyses to examine associations between racial identity and 
pain, quality of life, and coping. 
It was expected that racial identity would be associated with pain, quality of life, and 
coping where more positive racial identity would be associated with lower pain, higher quality of 
life, and more approach coping. 
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Figure 1. Hypothesized relation between pain, quality of life, and coping. Hypothesized relation 
between pain, quality of life, and coping, with approach coping moderating the relation between 
pain and quality of life in children with SCD. 
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CHAPTER 2 
METHOD 
Participants 
 Participants included 104 children diagnosed with SCD who ranged in age from 8 to 18 
years of age (M = 12.93 years, SD = 3.17 years) and who were receiving SCD-related care at two 
children’s medical facilities from March 2008 to July 2008 and their caregivers (See Table 1). 
Both clinics were located in an urban city in the southeastern United States and both had 
Caucasian and African American health care providers. Fifty-five children were female (52.9%) 
and 100 were African American (96.2%). In terms of SCD type, caregivers reported that 72 
(69.2%) children had SS, the most severe subtype, 13 (12.5%) had SC, 6 (5.8%) had Beta 
Thalassemia, and 13 (12.5%) did not specify their child’s type of SCD. 
 Most children were accompanied by a female caregiver (90 children, 86.5%), 88 (84.6%) 
of which were mothers (See Table 2). Caregivers ranged in age from 28 to 68 years (M = 40.84, 
SD = 7.92) and 100 (96.2%) self-identified as African American. Ninety-five caregivers (91.3%) 
reported their annual family income. Median family income in the sample was $40,001 to 
$50,000. Caregivers’ average years of education was 13.9 (SD = 2.1 years). Fifty-nine caregivers 
(56.7%) were married, 25 (24.0%) were single, 16 (15.4%) were divorced, 3 (2.9%) were 
separated, and 1 (1.0%) failed to report their marital status. 
115 children and their families were approached to participate in this study. Nine families 
(7.8%) did not wish to participate. The reasons for non-participation included not being 
interested in participating in research (7) and not having enough time to complete the measures 
(2). Therefore, 106 participants were enrolled in the study. However, 2 children (1.9%) did not 
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complete the main outcome measures due to time constraints, so they were removed from 
analyses. Therefore, the final sample consisted of 104 children with SCD and their parents. 
Measures 
Background information. Caregivers who accompanied participants for their SCD-related 
medical visit completed a background history form. Questions included child and caregiver age, 
child and caregiver races/ethnicities and genders, family income, and child’s current disease and 
medication status (Appendix A). 
Pain. The Pediatric Pain Questionnaire (PPQ; Varni & Thompson, 1985) was used to 
assess pain from the child’s perspective. The PPQ is a structured interview that allows for 
children to be interviewed individually and consists of different methods of assessing pain 
(Appendix B). Specifically, the PPQ consists of visual analogue scales (VAS) and open-ended 
questions. VASs are widely used in pediatric pain studies because they usually have good 
reliability and validity and do not result in the clustering of scores as is common with likert-type 
scales (Cohen et al., 2008; McGrath, 1990; Varni, Walco, & Wilcox, 1990). The VAS included 
in the PPQ is a 100 mm horizontal line that measures present pain and worst pain in the past 
week. The VAS questions are anchored at each end of the line with developmentally appropriate 
pain descriptions (e.g., No pain) and happy and sad faces. Scores on the PPQ range from 0 to 
100, with higher scores representing more pain. The open ended questions on the PPQ ask 
children to provide words that describe their pain and identify locations on their body where they 
are experiencing pain. The PPQ has demonstrated adequate reliability and validity in children 
with juvenile rheumatoid arthritis (Varni, Thompson, & Hanson, 1987) and demonstrated 
validity in a sample of children with SCD and their parents (Walco & Dampier, 1990). The PPQ 
has been deemed a “well-established” instrument for assessing children’s pain (Cohen et al., 
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2008). The internal consistency coefficient of the two PPQ VAS questions in this sample was 
0.59. An additional three items were added to the PPQ in order to assess chronic pain associated 
with SCD and children’s perceptions of pain. Cronbach’s alpha for these items was 0.65. A PPQ 
Total Pain score was calculated by averaging the three main pain scores obtained from the PPQ 
and additional items (e.g., Current Pain, Worst Pain, and Chronic Pain), which was used in the 
main analyses. 
Quality of life. The Pediatric Quality of Life Inventory (PedsQL; Varni, Seid, & Kurtin, 
2001) was completed by children to assess their quality of life (Appendix C). The PedsQL is a 
23-item generic quality of life measure designed for children and adolescents between 2 and 18 
years of age. In the current study, the PedsQL Child Report (ages 8-12) and the PedsQL Teen 
Report (ages 13-18), were utilized. Although the contents of the items are similar, the language 
for each version is developmentally appropriate for the specified age ranges. The PedsQL 
assesses several domains of functioning, including Physical (8 items), Emotional (5 items), 
Social (5 items), and School (5 items) and utilizes a 5-point likert scale (0 = never a problem to 4 
= almost always a problem). Scores on the PedsQL were reverse scored and transformed to 
scores ranging from 0 to 100, with higher scores representing higher quality of life. In addition to 
having specific scaled scores, the items on the PedsQL are averaged to create a Total Scale Score 
and two summary scores, the Physical Health Summary Score and the Psychosocial Health 
Summary Score. The PedsQL has been found to be valid and reliable for the Child and Teen 
Reports (Cronbach’s alphas ranged from 0.68 to 0.88) (Varni, Seid, & Kurtin, 2001) and is 
considered a “well-established” instrument (Palermo, Long, Lewandowski, Drotar, Quittner, & 
Walker, 2008). In a sample of children with SCD, Cronbach’s alpha ranged from 0.56 (School) 
to 0.79 (Physical) and the Total Score was 0.89 (McClellan, Schatz, Sanchez, & Roberts, 2008). 
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In this sample, Cronbach’s alpha for the PedsQL Total Score was 0.90. The internal consistency 
of the scales, measured by Cronbach’s alpha, ranged from 0.69 (School) to 0.86 (Physical). For 
the purposes of this study the PedsQL Total Score was used in primary analyses. 
To date there is no disease-specific measure of quality of life available for adults or 
children with SCD. Thus, the Sickle Cell Disease Quality of Life (SCD-QoL) measure was 
created for use in this study. Items included in the measure were selected based on previous 
qualitative research conducted in patients with SCD (Stegenga et al., 2004; Thomas & Taylor, 
2002), as well as with discussions with doctors and psychologists who work with pediatric 
patients with SCD. In addition, other disease-specific quality of life measures created for 
children with other chronic illnesses were examined to determine the appropriate formats and 
scales. The SCD-QoL consists of 28 items and scores ranged from (1 = Always to 4 = Never), 
with higher scores representing higher quality of life (Appendix D). The scores were transformed 
to a 0 to 100 scale, which is common in quality of life measures. Internal consistency for the 
entire measure was 0.92. The items were divided into four subscales, which included Physical, 
Emotional, Social, and School. Internal consistency for the different subscales ranged from 0.58 
(Social) to 0.81 (Physical). Concurrent validity of the SCD-QoL was examined via bivariate 
correlations with the PedsQL (See Table 3). Results revealed medium to large correlations 
between subscales of the SCD-QoL and the subscales of the PedsQL, suggesting adequate 
concurrent validity. 
Coping. To assess children’s pain coping strategies, the Pain Coping Questionnaire 
(PCQ; Reid, Gilbert, & McGrath, 1998) was utilized. The PCQ is a 39-item measure that 
consists of eight subscales, which were identified based on previous coping research conducted 
with adults and children (Appendix E). The subscales include: information seeking, problem 
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solving, seeking social support, positive self-statements, behavioral distraction, cognitive 
distraction, externalizing, and internalizing/catastrophizing. Higher-order factor analyses of the 
PCQ with healthy children and children with recurrent pain revealed three composites: approach, 
problem-focused avoidance, and emotion-focused avoidance (Reid et al., 1998). The approach 
scale assesses direct attempts to deal with pain and the use of active methods to regulate feelings 
when in pain. The approach scale is comprised of the information seeking, problem solving, 
seeking social support, and positive self-statements subscales. The problem-focused avoidance 
scale measures attempts to separate or disengage from the pain and consists of the positive self-
statements, behavioral distraction, and cognitive distraction subscales. The emotion-focused 
avoidance scale assesses strategies where emotions are freely expressed and reflect a lack of 
effort to regulate feelings when in pain. The emotion-focused avoidance composite consists of 
the externalizing and internalizing/catastrophizing subscales. Thus, the PCQ examines two of the 
most common coping dimensions utilized in pediatric research: problem-/emotion-focused and 
approach/avoidance. Children answered questions based on how often they engage in a particular 
coping strategy by using a 5-point likert scale (1 = never to 5 = very often). The PCQ was 
created for use with children 8 to 18 years of age and has a third grade reading level (Reid et al., 
1998). The measure has good internal consistency with Cronbach’s alphas for the subscales 
ranging from 0.78 to 0.86 and for the factors from 0.85 to 0.89. The measure also has shown 
high internal consistency in a large sample of adolescents (n = 631) experiencing chronic pain 
with no known etiology (Cronbach’s alphas for higher-order scales: 0.78 to 0.89; Merlijn et al., 
2003). In a review of coping measures, the PCQ was recognized as a “well-established” measure 
(Blount et al., 2008). In this sample, internal consistency ranged from 0.73 (Externalizing) to 
28 
0.82 (Behavioral Distraction) for the subscales and 0.78 (Emotion-Focused Avoidance) to 0.83 
(Approach) for the factors. The three PCQ factor scores were utilized in primary analyses. 
Racial identity. To assess children’s racial identity, the Multidimensional Inventory of 
Black Identity (MIBI; Sellers et al., 1997) was used (Appendix F). From this measure, two 
scales, Centrality (8 items) and Regard (12 items) were utilized. The Centrality scale examines 
the degree to which being African American is central to a person’s self-concept. The Regard 
scale consists of Private Regard and Public Regard. Private regard refers to whether individuals 
feel positively or negatively toward African Americans and their membership in that group 
(Sellers et al., 1997). Public regard refers to the extent to which individuals feel that others view 
African Americans positively or negatively (Sellers et al., 1997). A total of 20 MIBI items were 
administered to children in this study. Children rated how strongly they agreed or disagreed with 
each item on a likert scale with scores ranging from 1 to 7 (1 = Strongly disagree to 7 = Strongly 
agree). Higher scores indicated the belief that the child and others hold more positive attitudes 
towards African Americans. The MIBI has been found to be a valid and reliable measure of 
racial identity in a sample of African American college students, Cronbach’s alpha for the public 
regard scale was 0.78 and for the private regard scale was 0.78 (Sellers et al., 1997). In a study 
examining public regard and private regard in a sample of African American high school 
students Cronbach’s alphas were 0.75 for public regard and 0.76 for private regard (Rowley, 
Sellers, Chavous, & Smith, 1998). The MIBI was originally developed for adults. Therefore, 
some items were modified to help children in this study better understand the meaning of the 
items. In this sample, internal consistency of the Centrality Scale was 0.56 and the Regard Scale 
was 0.76 (Public Regard = 0.55 and Private Regard = 0.78). 
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Procedures 
 Children scheduled to receive SCD-related medical care at two urban children’s hospitals 
in the metro Atlanta area and their parents were informed of the study by clinic personnel and 
directed to receive additional information from a researcher. The trained research assistant 
further explained the study and obtained parent consent and child assent if the family was 
interested in participating. Before meeting with physicians, the child and caregiver completed 
measures in a quiet room in the clinic. Children completed the PPQ, PedsQL, SCD-QoL, PCQ, 
and MIBI. Parents completed the Background Information Form. 
Data Analyses Overview 
First, preliminary analyses consisting of descriptive statistics (e.g., means, standard 
deviations, frequencies) were used to characterize the sample. Specifically, demographic 
characteristics (e.g., age, gender) and study data (i.e., pain, quality of life, coping, racial identity) 
were detailed (See Table 3). In addition, preliminary analyses were conducted to examine the 
internal consistency of the study measures (e.g., PPQ, PedsQL, SCD-QoL, PCQ, and MIBI) with 
the obtained sample. Internal consistency was examined with Cronbach’s alpha. Finally, 
participant demographics (e.g., site of data collection, gender) were examined with respect to the 
study variables to examine if any covariates would be used in moderation analyses (Tables 5 and 
6). 
Primary analyses were conducted to determine whether coping (PCQ Approach Score) 
moderates the relation between pain (PPQ Total Score; independent variable) and quality of life 
(PedsQL Total Score; dependent variable) (Specific Aim #1). The variables (PPQ Total Pain and 
PCQ Approach Score) were first centered before main analyses were conducted to reduce 
multicollinearity. To test for moderation, three hierarchical regression equations were used, the 
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first of which included potential covariates. The second equation examined the main effects of 
pain and coping, and the final equation examined the variable representing the interaction 
between pain and coping. It was hypothesized that coping style would act as a protective factor 
in the relation between pain and quality of life, specifically that children experiencing high pain 
who utilize more approach coping strategies would have higher quality of life compared to 
children with high pain who utilize fewer approach coping strategies (See Figure 1). Additional 
regression analyses were also conducted to examine whether other types of coping (e.g., 
problem-focused avoidance, emotion-focused avoidance) moderated the relation between pain 
and quality of life. In addition, the SCD-QoL Total Score and subscales of both the PedsQL and 
the SCD-QoL were examined as dependent variables.  
To examine the impact of age on pain, quality of life, and coping (Specific Aim #2) 
correlations were utilized. These analyses were conducted in an exploratory nature due to the 
limited information available in the literature. However, it was hypothesized that age would be 
significantly associated with pain, as children with SCD are thought to experience more acute 
and chronic pain as they get older, report lower quality of life, and use more approach coping 
strategies. 
To evaluate the impact of racial identity on pain, quality of life, and coping (Specific Aim 
#3) correlations were also used. These analyses were also exploratory in nature yet it was 
hypothesized that more positive racial identity would be associated with lower pain, higher 
quality of life, and more approach coping. 
 Due to time limitations in the clinical setting, unwillingness to complete some questions, 
or inadvertently skipping some questions, some participants did not complete all items on the 
questionnaires and therefore did not have complete quality of life or coping data. For the main 
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study outcome variables, 6 participants were missing the PedsQL Total Score and 13 were 
missing the PCQ Approach Score. These data were left as missing points in analyses and other 
compensatory actions (e.g., inserting a mean value) were not taken. 
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Table 1 
Child Demographic Information (N = 104) 
 M (SD) 
Age  12.93 (3.17) 
 N (%) 
Gender  
     Female 55 (52.9) 
     Male 49 (47.1) 
Race/Ethnicity  
     African American 100 (96.1) 
     Asian 1 (1.0) 
     Not Reported 3 (2.9) 
SCD Type  
     HbSS 72 (69.2) 
     HbSC 13 (12.5) 
     Beta Thalassemia 6 (5.8) 
     Type not Specified 13 (12.5) 
 
33 
Table 2  
Parent Demographic Information (N = 104) 
 M (SD) 
Age  40.84 (7.92) 
 N (%) 
Gender   
     Female 90 (86.5) 
     Male 14 (13.5) 
Relationship to Child  
     Mother 88 (84.6) 
     Father 9 (8.7) 
     Grandmother 3 (2.9) 
     Grandfather 2 (1.9) 
     Stepfather 2 (1.9) 
Race/Ethnicity  
     African American  100 (96.1) 
     Native Hawaiian or Pacific Islander 1 (1.0) 
     Missing  3 (2.9) 
Marital Status  
     Married/Partnered 59 (56.7) 
     Single 25 (24.0) 
     Divorced 16 (15.4) 
     Separated 3 (2.9) 
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     Missing 1 (1.0) 
Education Level (M (SD) in years) 13.8 (2.1) 
Family Income   
     Up to $10,000 6 (5.8) 
     10,001- 20,000 10 (9.6) 
     20,001 – 30,000 12 (11.5) 
     30,001 – 40,000 14 (13.5) 
     40,001 – 50,000 11 (10.6) 
     50,001 – 60,000 10 (9.6) 
     60,001 – 70,000 6 (5.8) 
     70,001 – 80,000 7 (6.7) 
     80,001 – 90,000 3 (2.9) 
     90,001 and above 16 (15.1) 
     Not Reported 10 (9.6) 
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Table 3 
Concurrent Validity between the SCD-QoL and the PedsQL 
PedsQL Subscales SCD-QoL Subscales 
 Physical Emotional Social School Total 
Physical 0.72*** 0.61*** 0.57*** 0.65*** 0.76*** 
Emotional 0.59*** 0.61*** 0.46*** 0.49*** 0.63*** 
Social 0.48*** 0.47*** 0.54*** 0.60*** 0.59*** 
School 0.43*** 0.41*** 0.32** 0.59*** 0.50*** 
Total 0.71*** 0.64*** 0.60*** 0.72*** 0.78*** 
Note. ** p < 0.01, *** p < 0.001 
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CHAPTER 3 
RESULTS 
Preliminary Analyses 
First, descriptive statistics (e.g., means, standard deviations, frequencies) were utilized to 
characterize the sample on demographic variables (see Tables 1 and 2). Second, means and 
standard deviations of the study data (i.e., pain, quality of life, coping, racial identity) were 
obtained (See Table 4). Third, analyses were conducted to determine whether there were any 
differences between the two clinics where data was collected, with a focus on demographic 
characteristics and main outcome variables. Chi-square analyses indicated no site differences on 
child gender and type of SCD, as well as parent relation to child (See Table 5). Analyses with t-
tests revealed no significant differences between sites on child age, parent education level, and 
annual family income. However, results indicated a significant difference between sites on parent 
age, t (99) = -3.46, p < 0.001, where parents from the second site were older than parents from 
the first site. These results can be accounted for by the difference in the number of grandparents 
accompanying participating children across the different sites. One grandparent participated in 
the first site, while four participated in the second site. However, chi-square analyses did not 
reveal any significant differences between parent relation to child between the two sites. In 
addition, parent age was not found to be related to the main study outcomes so it was not 
controlled for in primary analyses.  
In regards to the main outcome variables, t-tests revealed no site differences on PPQ 
Total Pain and PCQ Approach Score. Yet, there was a site difference on the PedsQL Total Score, 
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where children from the second site reported significantly lower overall quality of life compared 
to children from the first site, t (96) = 2.38, p = 0.02 (See Table 5). In addition, there was a 
significant site difference on the SCD-QoL Total Score, where children from the second site 
reported lower quality of life compared to the first site, t (96) = 2.00, p = 0.05. A possible reason 
for the difference in quality of life between the two sites is likely due to the differences in the 
number of participants from each site that were recruited during an SCD specialty clinic. In the 
clinics where data collection occurred, children attended specialty SCD clinics if they 
experienced additional medical complications associated with SCD; and likely more impact on 
their quality of life. More children (n = 23) from the second site were attending a pulmonary 
SCD clinic compared to children from the first site (n = 13). In addition, four children from the 
second site were recruited while attending a SCD pain specialty clinic, while no children from 
the first site were recruited while attending a SCD pain specialty clinic. Due to the site 
differences on quality of life, site of participation was entered as a covariate in the main analyses. 
Fourth, potential gender differences were examined. Analyses with t-tests revealed that 
males and females reported significantly different overall generic quality of life on the PedsQL, t 
(96) = 1.99, p < 0.05, and overall disease-specific quality of life on the SCD-QoL, t (96) = 2.61, 
p < 0.05, with males reporting higher quality of life (See Table 6). In addition, there was a 
gender difference approaching significance on PCQ Approach Coping, with females reporting 
more approach coping than males, t (90) = -1.88, p = 0.06. Due to these findings, gender was 
also entered as a covariate in primary analyses.  
Primary Analyses 
The primary goal of this study was to examine whether coping moderates the relation 
between pain and quality of life (Specific Aim #1). To examine this aim, hierarchical regression 
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analyses were conducted. To control for potential site differences and child gender differences 
(see preliminary analyses above), site and gender were entered as covariates in the first step of 
the regression. Then, the centered pain and coping variables were entered in the second step. 
Next, the pain x coping interaction term was entered in the third step. The dependent variable for 
the regression analysis was quality of life (e.g., PedsQL Total Score). 
Results from the regression analysis examining approach coping revealed that the main 
effect of pain was a significant predictor of overall generic quality of life, β = -0.49, t (80) = -
4.94, p < 0.001 (See Table 7). Thus, children who reported higher pain (PPQ Total) also reported 
lower overall generic quality of life (PedsQL Total). There was no significant main effect of 
approach coping or significant pain x approach coping interaction for overall generic quality of 
life. 
As further exploratory tests of the primary aim, other indices of coping were examined. 
Regression analyses were conducted to determine whether problem-focused avoidance coping 
was a significant moderator between pain and quality of life. The main effect of pain was a 
significant predictor of overall generic quality of life (PedsQL Total), β = -0.48, t (88) = -5.16, p 
< 0.001 (See Table 7). There was no significant main effect of problem-focused avoidance 
coping or significant pain x problem-focused avoidance coping interaction for overall generic 
quality of life. An additional analysis was conducted to examine whether emotion-focused 
avoidance coping was a significant moderator of the pain and quality of life relation. The main 
effects of pain (β = -0.37, t (87) = -4.26, p < 0.001) and emotion-focused avoidance coping (β = -
0.39, t (87) = -4.64, p < 0.001) were significant predictors of overall generic quality of life 
(PedsQL Total; See Table 7), where higher pain was associated with lower overall generic 
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quality of life and higher emotion-focused avoidance coping was associated with lower quality 
of life. There was not a significant pain x emotion-focused avoidance coping interaction. 
The various subscales of the PedsQL were also entered in regression analyses as 
dependent variables to further examine the main purpose of this study. Results examining the 
PedsQL Physical Scale, PedsQL Emotion Scale, PedsQL Social Scale, and PedsQL School Scale 
as the dependent variables revealed similar results as above, where pain and emotion-focused 
avoidance coping were significant predictors of quality of life and there were no significant pain 
x coping interactions (See Tables 8 to 11).  
Disease-specific quality of life, the SCD-QoL Total Score, was also examined as the 
dependent variable in regression analyses to further examine whether coping moderates the 
relation between pain and quality of life. Results were similar to those found using the PedsQL 
Total Score as the dependent variable, where pain and emotion-focused avoidance coping were 
significant predictors of overall disease-specific quality of life (See Table 12) and no significant 
interaction between pain and coping styles were found.  
Additional regression analyses were conducted with subscales of the SCD-QoL entered 
as dependent variables to further examine the main aim of the study. Results of these analyses 
revealed significant main effects of pain and emotion-focused avoidance coping, similar to 
previous results (see Tables 13 to 16); with the exception of the SCD-QoL Social Score as pain 
was not a significant predictor of quality of life. In addition, these analyses revealed a significant 
interaction between pain and approach coping on the SCD-QoL Emotion Scale, β = 0.28, t (84) = 
2.85, p < 0.01 (See Table 14). Post hoc probing of this significant interaction was conducted, as 
recommended by Aiken and West (1991) and Holmbeck (2002). 
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Post-hoc probing of the significant interaction involved creating high (1 SD above the 
mean) and low (1 SD below the mean) approach coping moderator variables and two interaction 
terms, pain x high approach coping and pain x low approach coping. Two separate post-hoc 
regressions were then conducted to determine whether the high and low slopes were significant. 
In addition, these equations provided a regression equation to plot high (1 SD above the mean) 
and low (1 SD below the mean) pain scores. Post-hoc probing of the significant pain x approach 
coping interaction on SCD-QoL Emotion Scale revealed that at high approach coping, pain did 
not significantly predict quality of life. However, at low approach coping, pain was significantly 
inversely related to quality of life (See Figure 2). 
 To further explore gender differences, hierarchical regression analyses were conducted 
separately for males and females (See Appendix G). These analyses revealed similar results as 
above for both males and females, where pain and emotion-focused avoidance coping were 
significant predictors of both generic and disease-specific quality of life. In addition, for males, 
approach coping was a significant predictor of SCD-QoL School Score, β = -0.42, t (37) = -2.48, 
p < 0.05 (See Appendix G, Table 10). There was also a main effect approaching significance for 
approach coping predicting SCD-QoL Total Score, β = -0.28, t (36) = -1.80, p = 0.08 (See 
Appendix G, Table 6). For females, there was also a significant main effect of approach coping 
on SCD-QoL School Score, β = 0.30, t (40) = 2.12, p < 0.05 (See Appendix G, Table 10) and an 
approaching significance main effect of problem-focused avoidance coping on SCD-QoL Social 
Score, β = 0.27, t (46) = 1.82, p = 0.08 (See Appendix G, Table 9). An interaction approached 
significance between pain and approach coping for both the PedsQL Emotion Score β = 0.32, t 
(41) = 1.95, p = 0.06 (See Appendix G, Table 3) and the SCD-QoL Emotion Score, β = 0.33, t 
(42) = 1.88, p = 0.07 (See Appendix G, Table 8).  
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Exploratory Analyses 
To examine the association between child age and the study variables (Specific Aim #2), 
bivariate correlational analyses were conducted (See Table 17). No significant correlations were 
found. To examine the possible relation between racial identity and the outcome variables 
(Specific Aim #3), bivariate correlational analyses were also conducted (See Table 18). Results 
of these analyses revealed that the MIBI Centrality Scale was negatively correlated with PCQ 
Approach Coping, r (80) = -0.24, p < 0.05, with higher racial centrality associated with lower 
approach coping. The MIBI Centrality Scale was also significantly positively correlated with the 
SCD-QoL Total Score, r (88) = 0.29, p < 0.01, with higher racial centrality associated with 
higher disease-specific quality of life. The MIBI Regard Scale was significantly positively 
correlated with PCQ Problem-Focused Avoidance Coping, r (84) = 0.30, p < 0.01 and with SCD-
QoL Total Score, r (82) = 0.27, p < 0.05, with higher regard associated with higher problem-
focused avoidance coping and higher disease-specific quality of life. In terms of regard type, the 
MIBI Private Regard Scale was significantly positively correlated with PCQ Problem-Focused 
Avoidance Coping, r (88) = 0.28, p < 0.01, with higher public regard associated with higher 
problem-focused avoidance coping. The MIBI Public Regard Scale was positively correlated 
with PedsQL Total Score, r (86) = 0.22, p < 0.05, with SCD-QoL Total Score, r (85) = 0.29, p < 
0.01, with PCQ Problem-Focused Avoidance Coping, r (88) = 0.22, p < 0.01, with higher public 
regard associated with higher generic overall quality of life, higher disease-specific quality of 
life, and higher problem-focused avoidance coping. In addition, the correlation between the 
MIBI Public Regard Scale and PCQ Emotion-Focused Avoidance Coping approached 
significance, r (85) = -0.20, p = 0.072.  
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Table 4 
Means and Standard Deviations of Study Variables 
Measures M (SD) 
Pediatric Pain Question (PPQ) a  
     Current Pain 12.70 (22.81) 
     Worst Pain 29.46 (34.57) 
     Chronic Pain 21.12 (28.86) 
     Total Pain 21.09 (24.48) 
Pediatric Quality of Life Inventory (PedsQL) b  
     Physical Score 69.09 (21.18) 
     Emotional Score 71.32 (20.67) 
     Social Score 80.29 (18.95) 
     School Score 62.07 (19.34) 
     Total Score 70.61 (16.33) 
Sickle Cell Disease Quality of Life (SCD-QoL) c  
     Physical Score 75.22 (15.82) 
     Emotional Score 80.74 (15.36) 
     Social Score 78.98 (15.09) 
     School Score 81.66 (14.38) 
     Overall Score 78.74 (13.46) 
Pain Coping Questionnaire (PCQ) d  
     Approach Coping 3.04 (0.60) 
     Problem-Focused Avoidance Coping 2.79 (0.80) 
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     Emotion-Focused Avoidance Coping 1.85 (0.63) 
Multidimensional Inventory of Black Identity (MIBI) e  
     Centrality 4.65 (1.06) 
     Regard 5.34 (0.85) 
          Private Regard 6.18 (1.07) 
          Public Regard 4.48 (0.93) 
Note. a Scores on the PPQ range from 0 to 100, with higher scores representing more pain. b 
Scores on the PedsQL range from 0 to 100, with higher scores representing higher quality of life. 
c On the SCD-QoL scores range from 0 to 100, with higher scores representing higher quality of 
life. d Scores on the PCQ range from 1 to 5, with higher scores representing more frequent use of 
the coping strategy. e On the MIBI scores range from 1 to 7, with higher scores indicating a more 
positive perception of African-Americans. 
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Table 5 
Examination of Site Differences 
 Site  
 
Variables 
Site 1  
(n = 54) 
Site 2  
(n = 50) 
 
Chi square 
Child Gender (% Female) 55.6 50.0 X2 (1) = 0.32 
Type of SCD (% SS) 77.6 77.3 X2 (3) = 2.71 
Parent Relation to Child (% Mothers) 90.7 78.0 X2 (3) = 4.90 
Variables M (SD) M (SD) t-tests 
Child Age  12.66 (3.17) 13.23 (3.18) t (102) = -0.93 
Parent Age 38.33 (5.98) 43.51 (8.87) t (99) = -3.46*** 
Parent Education Level (in years) 13.81 (2.37) 13.91 (1.77) t (100) = -0.26 
Annual Family Income a 5.00 (2.67) 5.94 (3.02) t (93) = -1.60 
PPQ Total Pain  20.05 (26.18) 22.22 (22.72) t (102) = -0.45 
PedsQL Total Score  74.37 (14.47) 66.69 (17.36) t (96) = 2.38* 
SCD-QoL Total Score 81.30 (12.82) 75.95 (13.71) t (96) = 2.00* 
PCQ Approach Coping 3.00 (0.67) 3.07 (0.53) t (89) = -0.56 
PCQ Problem-Focused Avoidance Coping 2.74 (0.82) 2.85 (0.79) t (98) = -0.96 
PCQ Emotion-Focused Avoidance Coping 1.81 (0.64) 1.89 (0.62) t (96) = -0.63 
Note. a Family income ranged from 1 = Up to $10,000 to 10 = $90,000 and above. * p < 0.05, 
*** p < 0.001.  
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Table 6 
Examination of Gender Differences 
  Gender 
 
Males  
(n = 49) 
Females 
(n = 55)  
Variables M (SD) M (SD) t-tests 
PPQ Total Pain 17.02 (21.77) 24.72 (26.34) t (102) = -1.61  
PedsQL Total Score 73.91 (16.81) 67.43 (15.35) t (96) = 1.99*  
SCD-QoL Total Score 82.40 (12.70) 75.50 (13.39) t (96) = 2.61*  
PCQ Approach Coping 2.91 (0.57) 3.15 (0.62) t (90) = -1.88† 
PCQ Problem-Focused Avoidance Coping 2.82 (0.83) 2.76 (0.78) t (98) = 0.36 
PCQ Emotion-Focused Avoidance Coping 1.78 (0.65) 1.91 (0.61) t (96) = -1.02 
Note. † p < 0.10, * p < 0.05 
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Table 7 
Regressions of Pain and Coping Types on Generic Overall Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 86) 
Step 1  0.075 0.075   3.387* 
     Site  -0.184†    
     Gender -0.100    
Step 2  0.299 0.224 13.130*** 
     Total Pain -0.493***    
     Approach Coping -0.036    
Step 3  0.302 0.003   0.293 
     Total Pain x Approach Coping  0.054    
Problem-Focused Avoidance Coping (N = 94) 
Step 1  0.107 0.107   5.512** 
     Site -0.227*    
     Gender -0.124    
Step 2  0.326 0.219 14.627*** 
     Total Pain -0.476***    
     Problem-Focused Avoidance (PFA)  0.073    
Step 3  0.326 0.000   0.006 
     Total Pain x PFA Coping -0.007    
Emotion-Focused Avoidance Coping (N = 93) 
Step 1  0.101 0.101 5.089** 
     Site -0.217**    
     Gender -0.102    
Step 2  0.440 0.340 27.024*** 
     Total Pain -0.372***    
     Emotion-Focused Avoidance (EFA) -0.391***    
Step 3  0.441 0.001 0.085 
     Total Pain x EFA Coping  0.025    
Note. Dependent variable = PedsQL Total Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001.
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Table 8 
Regressions of Pain and Coping Types on Generic Physical Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 87) 
Step 1  0.075 0.075   3.453* 
     Site -0.185*    
     Gender -0.096    
Step 2  0.301 0.226 13.403*** 
     Total Pain -0.475***    
     Approach Coping -0.050    
Step 3  0.301 0.000   0.000 
     Total Pain x Approach Coping 0.000    
Problem-Focused Avoidance Coping (N = 95) 
Step 1  0.113 0.113   5.930** 
     Site -0.235**    
     Gender -0.121    
Step 2  0.329 0.216 14.620*** 
     Total Pain -0.452***    
     Problem-Focused Avoidance (PFA)  0.074    
Step 3  0.334 0.006   0.750 
     Total Pain x PFA Coping -0.080    
Emotion-Focused Avoidance Coping (N = 94) 
Step 1  0.104 0.104   5.316** 
     Site -0.231**    
     Gender -0.125    
Step 2  0.329 0.225 15.087*** 
     Total Pain -0.397***    
     Emotion-Focused Avoidance (EFA) -0.204*    
Step 3  0.329 0.000   0.015 
     Total Pain x EFA Coping  0.012    
Note. Dependent variable is PedsQL Physical Score. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 9 
Regressions of Pain and Coping Types on Generic Emotional Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 89) 
Step 1  0.083 0.083 3.913* 
     Site -0.134    
     Gender -0.189†    
Step 2  0.208 0.126 6.746** 
     Total Pain -0.375***    
     Approach Coping -0.078    
Step 3  0.222 0.014 1.527 
     Total Pain x Approach Coping 0.127    
Problem-Focused Avoidance Coping (N = 98) 
Step 1   0.070 0.070 3.630* 
     Site -0.147    
    Gender -0.165†    
Step 2  0.197 0.127 7.420** 
     Total Pain -0.374***    
     Problem-Focused Avoidance (PFA)  0.142    
Step 3  0.204 0.007 0.766 
     Total Pain x PFA Coping  0.087    
Emotion-Focused Avoidance Coping (N = 96) 
Step 1  0.065 0.065   3.286* 
     Site -0.113    
     Gender -0.129    
Step 2  0.398 0.333 25.447*** 
     Total Pain -0.221*    
     Emotion-Focused Avoidance (EFA) -0.486***    
Step 3  0.398 0.000   0.013 
     Total Pain x EFA Coping -0.010    
Note. Dependent variable is PedsQL Emotion Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001 
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Table 10 
Regressions of Pain and Coping Types on Generic Social Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 90) 
Step 1  0.026 0.026 1.152 
     Site -0.127    
     Gender -0.041    
Step 2  0.133 0.107 5.327** 
     Total Pain -0.356***    
     Approach Coping  0.045    
Step 3  0.137 0.004 0.405 
     Total Pain x Approach Coping  0.068    
Problem-Focused Avoidance Coping (N = 99) 
Step 1  0.048 0.048 2.434† 
     Site -0.152    
     Gender -0.095    
Step 2  0.143 0.095 5.252** 
     Total Pain -0.323**    
     Problem-Focused Avoidance (PFA)  0.004    
Step 3  0.144 0.002 0.187 
     Total Pain x PFA Coping  0.045    
Emotion-Focused Avoidance Coping (N =97) 
Step 1  0.056 0.056   2.840† 
     Site -0.177    
     Gender -0.039    
Step 2  0.309 0.253 17.015*** 
     Total Pain -0.264**    
     Emotion-Focused Avoidance (EFA) -0.417***    
Step 3  0.317 0.008   1.103 
     Total Pain x EFA Coping  0.099    
Note. Dependent variable is PedsQL Social Score. a Site and Child Gender were originally 
entered in Step 1 but were not retained as covariates. † p < 0.10, ** p < 0.01, *** p < 0.001 
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 Table 11 
Regressions of Pain and Coping Types on Generic School Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 90) 
Step 1  0.025 0.025 1.149 
     Site -0.133    
     Gender  0.015    
Step 2  0.155 0.130 6.612** 
     Total Pain -0.362***    
     Approach Coping -0.050    
Step 3  0.156 0.001 0.056 
     Total Pain x Approach Coping  0.025    
Problem-Focused Avoidance Coping (N = 99) 
Step 1  0.046 0.046 2.341 
     Site -0.172†    
     Gender -0.020    
Step 2  0.178 0.132 7.638*** 
     Total Pain -0.361***    
     Problem-Focused Avoidance (PFA)  0.016    
Step 3  0.180 0.002 0.189 
     Total Pain x PFA Coping -0.044    
Emotion-Focused Avoidance Coping (N = 97) 
Step 1   0.045 0.045   2.239 
     Site  -0.176†    
     Gender  0.005    
Step 2  0.232 0.187 11.301 
     Total Pain -0.295**    
     Emotion-Focused Avoidance (EFA) -0.270**    
Step 3  0.232 0.000   0.025 
     Total Pain x EFA Coping  0.016    
Note. Dependent variable is PedsQL School Score. † p < 0.10, ** p < 0.01, *** p < 0.001. 
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Table 12 
Regressions of Pain and Coping Types on Disease-specific Overall Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 86) 
Step 1  0.114 0.114   5.431** 
     Site -0.167†    
     Gender -0.224*    
Step 2  0.306 0.192 11.346*** 
     Total Pain -0.454***    
     Approach Coping    -0.038    
Step 3  0.316 0.009   1.076 
     Total Pain x Approach Coping     0.099    
Problem-Focused Avoidance Coping (N = 94) 
Step 1  0.117 0.117   6.097** 
     Site -0.179*    
     Gender -0.203*    
Step 2  0.313 0.196 12.848*** 
     Total Pain -0.435***    
     Problem-Focused Avoidance (PFA)  0.086    
Step 3  0.316 0.003   0.331 
     Total Pain x PFA Coping -0.055    
Emotion-Focused Avoidance Coping (N = 91) 
Step 1  0.106 0.106   5.304** 
     Site -0.178*    
     Gender -0.166*    
Step 2  0.449 0.342 26.991*** 
     Total Pain -0.325***    
     Emotion-Focused Avoidance (EFA) -0.439***    
Step 3  0.451 0.003   0.436 
     Total Pain x EFA Coping  0.062    
Note. Dependent variable is SCD-QoL Total Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 13 
Regressions of Pain and Coping Types on Disease-specific Physical Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 88) 
Step 1  0.073 0.073   3.374* 
     Site -0.123    
     Gender -0.127    
Step 2  0.349 0.276 17.823*** 
     Total Pain -0.514***    
     Approach Coping -0.127    
Step 3  0.353 0.004   0.571 
     Total Pain x Approach Coping  0.069    
Problem-Focused Avoidance Coping (N = 96) 
Step 1  0.072 0.072   3.673* 
     Site -0.147†    
     Gender -0.109    
Step 2  0.341 0.269 18.747*** 
     Total Pain -0.514***    
     Problem-Focused Avoidance (PFA)  0.080    
Step 3  0.344 0.003   0.392 
     Total Pain x PFA Coping -0.058    
Emotion-Focused Avoidance Coping (N = 93) 
Step 1  0.060 0.060   2.920† 
     Site -0.140†    
     Gender -0.079    
Step 2  0.436 0.375 29.594*** 
     Total Pain -0.402***    
     Emotion-Focused Avoidance (EFA) -0.392***    
Step 3  0.437 0.001   0.201 
     Total Pain x EFA Coping 0.042    
Note. Dependent variable is SCD-QoL Physical Score. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 14 
Regressions of Pain and Coping Types on Disease-specific Emotional Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 90) 
Step 1  0.098 0.098 4.778* 
     Site -0.151    
     Gender -0.242*    
Step 2  0.212 0.114 6.221** 
     Total Pain -0.423***    
     Approach Coping  0.001    
Step 3  0.281 0.069 8.134** 
     Total Pain x Approach Coping  0.280**    
Problem-Focused Avoidance Coping (N = 99) 
Step 1   0.069 0.069 3.613* 
     Site -0.144    
    Gender -0.157    
Step 2  0.186 0.116 6.783** 
     Total Pain -0.331***    
     Problem-Focused Avoidance (PFA)  0.130    
Step 3  0.186 0.000 0.008 
     Total Pain x PFA Coping -0.009    
Emotion-Focused Avoidance Coping (N = 97) 
Step 1  0.068 0.068   3.465* 
     Site -0.118    
     Gender -0.140    
Step 2  0.364 0.296 21.650*** 
     Total Pain -0.218*    
     Emotion-Focused Avoidance (EFA) -0.446***    
Step 3  0.365 0.001   0.119 
     Total Pain x EFA Coping -0.031    
Note. Dependent variable is SCD-QoL Emotion Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p 
< 0.001 
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Table 15 
Regressions of Pain and Coping Types on Disease-specific Social Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 89) 
Step 1  0.060 0.060 2.783† 
     Site -0.172    
     Gender -0.167    
Step 2  0.099 0.039 1.858 
     Total Pain -0.216†    
     Approach Coping  0.050    
Step 3  0.101 0.002 0.161 
     Total Pain x Approach Coping  0.044    
Problem-Focused Avoidance Coping (N = 98) 
Step 1  0.083 0.083 4.364 
     Site -0.192*    
     Gender -0.193†    
Step 2  0.142 0.059 3.234 
     Total Pain -0.212*    
     Problem-Focused Avoidance (PFA)  0.167†    
Step 3  0.143 0.001 0.096 
     Total Pain x PFA Coping 0.032    
Emotion-Focused Avoidance Coping (N = 96) 
Step 1  0.085 0.085   4.340* 
     Site -0.196*    
     Gender -0.142    
Step 2  0.267 0.182 11.418*** 
     Total Pain -0.102    
     Emotion-Focused Avoidance (EFA) -0.425***    
Step 3  0.275 0.008   1.042 
     Total Pain x EFA Coping  0.100    
Note. Dependent variable is SCD-QoL Social Score. † p < 0.10, * p < 0.05, *** p < 0.001. 
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Table 16 
Regressions of Pain and Coping Types on Disease-specific School Quality of Life 
Variables β R2 R2 Change F Change 
Approach Coping (N = 88) 
Step 1  0.141 0.141 7.058*** 
     Site -0.225*    
     Gender -0.272**    
Step 2  0.257 0.116 6.551** 
     Total Pain -0.384***    
     Approach Coping  0.042    
Step 3  0.269 0.012 1.346 
     Total Pain x Approach Coping  0.116    
Problem-Focused Avoidance Coping (N = 97) 
Step 1  0.160 0.160 9.015 
     Site -0.233*    
     Gender -0.275**    
Step 2  0.263 0.104 6.531 
     Total Pain -0.339***    
     Problem-Focused Avoidance (PFA)  0.017    
Step 3  0.265 0.002 0.243 
     Total Pain x PFA Coping  0.048    
Emotion-Focused Avoidance Coping (N = 95) 
Step 1   0.141 0.141   7.661*** 
     Site  -0.225*    
     Gender -0.234*    
Step 2  0.297 0.155 10.063*** 
     Total Pain -0.242*    
     Emotion-Focused Avoidance (EFA) -0.286**    
Step 3  0.298 0.001   0.173 
     Total Pain x EFA Coping  0.040    
Note. Dependent variable is SCD-QoL School Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 17 
Associations between Age and Main Study Variables 
Variables Child Age 
PPQ Total Pain  0.12 
PedsQL Total Score  0.03 
SCD-QoL Total Score -0.04 
PCQ Approach Coping -0.03 
PCQ Problem-Focused Avoidance Coping -0.16 
PCQ Emotion-Focused Avoidance Coping  0.01 
Note. No significant correlations found. 
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Table 18 
Associations between Racial Identity and Main Study Variables 
 MIBI Scales 
Variables Centrality Regard Private 
Regard 
Public 
Regard 
PPQ Total Pain -0.09 -0.08  0.02 -0.16 
PedsQL Total   0.09  0.14  0.06  0.22* 
SCD-QoL Total 0.29** 0.27* 0.18† 0.29** 
PCQ Approach Coping -0.24*  0.13  0.12  0.10 
PCQ Problem-Focused Avoidance Coping  0.05  0.30**  0.28**  0.22* 
PCQ Emotion-Focused Avoidance Coping -0.03 -0.18 -0.15 -0.20† 
Note. † p < 0.10, * p < 0.05, ** p < 0.01 
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Figure 2. Post-hoc Probing of Interaction between Pain and Approach Coping on SCD-QoL 
Emotion Score. SCD-QoL Emotional Functioning as a function of Pain and Approach Coping 1 
standard deviation above and 1 standard deviation below the mean in children with SCD. 
Note. *** p < 0.001 
(b = -0.45)*** 
(b = -0.09) 
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CHAPTER 4 
DISCUSSION 
 This study examined whether coping moderates the relation between pain and quality of 
life in children with sickle cell disease (SCD). In addition, the potential roles of development and 
racial identity were investigated. 
Relation between Pain, Quality of Life, and Coping 
This is one of the first studies to examine the relation between pain and quality of life in 
children with SCD. Results revealed that children’s pain significantly predicted their quality of 
life, where higher pain was associated with lower quality of life. This finding is consistent with 
prior research conducted with adolescents with chronic pain (Merlijn et al., 2003), adults with 
SCD (Anie et al., 2002), and children with SCD when a non-standardized measure of quality of 
life (i.e., four questions about daily activities) was utilized (Fuggle et al., 1996). 
The link between pain and quality of life can be explained in numerous ways. It is likely 
that acute and chronic pain influence various areas of quality of life. For example, acute pain 
episodes are associated with significant physical symptoms that have been found to interfere 
with school attendance and interactions with peers (Gil et al., 2000; Shapiro et al., 1995), which 
may lead to decreased quality of life in the physical, social, and/or academic domains. Pain 
experiences may also lead to children with SCD viewing their everyday functioning more 
negatively, thus impacting their self-reported quality of life. However, due to the correlational 
nature of this study causality cannot be determined, and other explanations must be considered. It 
may be that children with lower quality of life who experience acute and chronic pain may 
60 
experience additional negative impacts on their daily functioning, which thus negatively impacts 
quality of life. Lower quality of life in children with SCD may lead to negative perceptions about 
painful experiences, which may lead to higher ratings of pain. This study found that pain and 
quality of life are associated; however, the mechanisms through which this occurs are unclear 
and further research is warranted. 
Previous studies have relied on medical chart reviews to determine disease related 
factors, including pain, that impact quality of life in children with SCD. One study found that 
disease status was related to physical functioning on a parent-report quality of life measure (e.g., 
CHQ; Panepinto et al., 2005). In addition, a recent study by McClellan et al. (2008) found that 
children with SCD who had a history of pain episodes reported significantly lower quality of life 
on most scales of the PedsQL, with the exception of the Emotional Scale, compared to children 
without a significant pain history. However, pain history in their study was determined by a 
retrospective two-year medical chart review and child or parent report of pain was not obtained. 
The current study is one of the first to examine the relation between pain and quality of life in 
children with SCD by utilizing children’s self-report of both constructs. The findings from this 
study suggest that prospective child-report of pain and quality of life are important to consider. 
In addition, it suggests that children’s report of these measures should be included in pediatric 
intervention research involving children with SCD if changes in these constructs are of interest.  
The central hypothesis of this study, that coping would moderate the relation between 
pain and quality of life, was not supported. Specifically, approach coping, problem-focused 
avoidance coping, and emotion-focused avoidance coping were not found to influence the 
relation between pain and overall quality of life in this sample of children with SCD. Thus, 
results from this study do not support the model linking pain, quality of life, and coping as 
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proposed by Merlijn et al. (2005). There are numerous reasons why the results from this study 
are inconsistent with past research. First, Merlijn and colleagues’ (2003, 2005, 2006) model of 
pain, quality of life, and coping was based on research conducted with Dutch adolescents with 
non-specific chronic pain, such as headache, back pain, limb pain, and abdominal pain. Thus, 
participants in these studies differed in numerous ways. For example, participants in the current 
study experienced pain in the context of a chronic illness, whereas participants in the Merlijn et 
al. studies did not have a chronic illness. Also participants in the current study included children 
and adolescents ranging in age from 8 to 18 who predominately African American. Merlijn et al. 
targeted Dutch adolescents who were 12 to 18 years of age. Thus, developmental, racial/ethnic, 
and cultural differences might explain differences in findings between the studies. Second, 
measurement differences could have also contributed to the inconsistent findings. Merlijn and 
colleagues utilized a chronic pain specific quality of life measure, whereas this study utilized 
generic and disease-specific pediatric quality of life measures. In addition, the measures of pain 
between the studies also differed. This study utilized the PPQ (Varni & Thompson, 1985), 
whereas Merlijn et al. utilized a measure created by Perquin et al. (2000), but pain was assessed 
in similar ways across both measures (e.g., visual analogue scales). Yet, the same coping 
measure, the Pain Coping Questionnaire, was utilized in both studies, although it was translated 
into Dutch in the Merlijn and colleagues’ studies. 
However, when the relations between pain, specific domains of quality of life, and coping 
were further examined, results revealed a significant interaction between pain and approach 
coping on the SCD-specific emotional quality of life subscale. This finding suggests that 
approach coping moderates the relation between pain and SCD-specific emotional functioning 
and is consistent with the model proposed by Merlijn and colleagues. On the other hand, no other 
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significant interactions between pain and coping were found in this study, and this finding may 
be an artifact due to the high number of analyses conducted. 
Significant relations between quality of life and emotion-focused avoidance coping, but 
not approach or problem-focused avoidance coping, were found in this study, with higher 
emotion-focused avoidance coping associated with lower quality of life. For example, children in 
this study who endorsed coping efforts that were ineffective at regulating their feelings when in 
pain also endorsed lower every day functioning. Thus, this finding suggests that emotion-focused 
avoidance coping in children with SCD is associated with poorer functioning. 
This result is consistent with prior research conducted with adult patients with SCD. Anie 
et al. (2002) found that affective coping on the CSQ-SCD was associated with poorer quality of 
life on physical, social, and emotional domains of functioning; however, other types of coping, 
such as active coping and passive adherence were not associated with quality of life. 
Associations between quality of life and coping have also been found in adults with other 
chronic illnesses (e.g., cystic fibrosis; Abbott, Hart, Morton, Gee, & Conway, 2008). In 
adolescents with chronic pain, Merlijn et al. (2006) found that coping was associated with quality 
of life. Specifically, emotion-focused avoidance coping was negatively associated with 
psychological functioning and satisfaction with health, which were subscales on the chronic pain 
specific quality of life measure utilized. Results from this study were similar to the findings in 
the current study. Another study examined quality of life and coping in children with chronic 
illnesses (e.g., asthma, diabetes, and arthritis) and found associations between quality of life and 
types of coping (wishful thinking and distance on the Coping with a Disease measure; Petersen, 
Schmidt, Bullinger, & the DISABKIDS Group, 2006). Possible reasons for some of the 
contradictory findings are likely due to differences in participants and measures utilized in the 
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current and past studies. The lack of consistent definitions of coping and the multiple types of 
coping examined also further complicate efforts to compare findings specific to coping across 
studies. However, the current findings emphasize the importance of examining emotion-focused 
avoidance coping in children with SCD. Given the complexity of coping and the complex 
literature focusing on it, continued examination of pain, quality of life, and coping in children 
with SCD is warranted. 
Gender Differences 
 Preliminary results from this study found that there were significant differences in quality 
of life between males and females with SCD. Specifically, males reported higher overall generic 
and disease-specific quality of life compared to females. This finding is consistent with a past 
study, which found that female gender predicted lower parent proxy report of quality of life in 
children with SCD (Palermo et al., 2002). A reason for the finding in the Palermo et al. (2002) 
study could be related to parents’ differing perceptions between the everyday functioning of 
males and females with SCD. However, child report was examined in this study. Additionally, 
females in this study endorsed more pain compared to males. Although this difference was not 
statistically significant it is possible that the difference in quality of life may be accounted for by 
differences in pain. Given the gender differences in quality of life, primary analyses were also 
run separately in order to examine specific main effects of pain and coping, as well as the 
interaction between pain and coping for both genders. 
Pain and emotion-focused avoidance coping were found to be important predictors of 
quality of life in both males and females. In addition, approach coping was a significant predictor 
of disease-specific school quality of life in both males and females. However, the directions of 
the relations were different; approach coping was negatively associated with quality of life in 
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boys but positively associated with quality of life in girls. For example, in boys with SCD asking 
questions about their disease-related pain and talking with others about their pain may be related 
to decreased school functioning but for girls these strategies are related to better school 
functioning. Therefore, approach coping might serve a protective function for girls but not boys 
in academic settings. 
 Potential reasons for this finding are numerous. However, gender socialization related to 
coping with painful experiences seems important to consider. Boys are typically taught that 
crying or reporting that they are in pain is not socially acceptable, whereas it is often more 
acceptable for girls to express pain via crying or talking with others. Gender differences in 
coping and social support have been found in adults (Gurung, 2006). Research with adults 
suggests that females are more likely to mobilize social support and are more engaged in social 
networks compared to males (Gurung, 2006). In addition, it has been suggested that girls may be 
more sensitive than boys to pain-reinforcing social contingencies (Dahlquist & Switkin, 2003), 
which could impact pain coping strategies, especially related to seeking support and talking 
about painful experiences. However, it is interesting that gender differences were found for 
approach coping and not problem- or emotion-focused avoidance in this sample of children with 
SCD. It is likely that important developmental and cultural factors are also playing a role in the 
coping strategies endorsed by children in this study. If similar gender differences in coping are 
found across studies, there may be implications for the design and implementation of coping 
interventions, where specific coping skills may be more appropriate to teach girls with SCD than 
boys with SCD. 
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Developmental Issues 
A secondary aim of this study was to examine the relation between child age and the 
main outcome variables (e.g., pain, quality of life, coping). Contrary to expectations, age was not 
related to pain, quality of life, or coping in this study. This is inconsistent with the hypothesis 
that SCD pain-related complications are progressive in nature. In addition, it is not consistent 
with past research in healthy children, which suggests that symptoms of recurrent pain increase 
as children get older (Petersen, Brulin, & Bergstrom, 2006). However, the lack of correlations 
between age and pain may be explained by children with SCD becoming familiar with 
experiencing acute and chronic pain associated with the disease. For example, older children 
may not rate their pain experience as being as intense as younger children due to the number of 
pain episodes and disease complications they may have experienced. It may be that the 
perception of disease-related pain changes over time, which impacts the level of pain 
endorsement and accounts for the lack of age-related associations.   
The lack of associations between child age and quality of life is also inconsistent with a 
prior study, which found that age and the physical functioning domain of quality of life in SCD 
were inversely related; however, this result was not found on the psychosocial functioning 
domain (Palermo et al., 2002). Finer grained analyses of age and domains of quality of life in 
SCD might be in order. Examining specific domains of quality of life (e.g., social, emotional, 
etc.) via longitudinal research studies would allow for more in-depth analyses of developmental 
changes. In addition, quality of life in the Palermo et al. (2002) study was based on parent report, 
whereas this study focused on child report of quality of life. Difference in reporters might also 
explain discrepancies between the two investigations. 
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The lack of associations between child age and coping is inconsistent with some findings 
but consistent with others. One study found that types of coping, such as emotion-focused 
coping, increase as children get older (Compas et al., 1992). In addition, Gil et al. (1991) found 
that in children with SCD passive adherence was positively correlated with child age. However, 
other studies have not found a significant relation between coping strategies and child age in 
pediatric SCD (Gil et al., 1997), which is similar to findings from this study. Continuing to 
examine the relation between coping strategies and child age is warranted. In addition, 
longitudinal research examining prospective changes in pain, quality of life, and coping is in 
order due to the progressive nature of SCD and the inconsistent findings from this and prior 
studies. 
Racial Identity 
This was one of the first studies to examine racial identity in children with SCD. Racial 
identity was found to be associated with overall quality of life and coping. Public regard, the 
extent to which a person feels others positively view African Americans (Sellers et al., 1997), 
was positively associated with higher generic and disease-specific overall quality of life in 
children with SCD. This finding is consistent with Bediako et al. (2007), which posited that 
positive racial identity in African American adults with SCD may be related to improved health. 
Thus, it appears that public regard may act as a protective factor for quality of life in children 
with SCD. 
Centrality, whether race makes up an important part of an individual’s self-concept 
(Sellers et al., 1997), was found to positively correlate with SCD-specific overall quality of life, 
where higher racial centrality was associated with higher quality of life. In addition, centrality 
was found to negatively correlate with approach coping. Thus, higher centrality, or race being a 
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more central part of one’s self-concept, was associated with lower approach coping. Therefore, 
decreased information seeking, problem solving, seeking social support, and positive self-
statements were associated with higher centrality. In addition, regard, or positive feelings about 
being Black, was positively associated with problem-focused avoidance coping. These findings 
suggest that racial identity may influence the strategies that children with SCD utilize to cope 
with disease-related pain. 
This is one of the first studies to examine pain, quality of life, coping, and racial identity 
in children with SCD; thus, caution should be taken when interpreting findings. One study with 
adults with SCD found that higher centrality was associated with lower pain ratings (Bediako et 
al., 2007). The experiences of African Americans, such as experiencing racism and prejudice, 
could be a possible reason for the association between pain and racial identity. However, 
significant associations between racial identity and pain were not found in this study of children 
with SCD. This was one of the first attempts to examine cultural factors in children with SCD 
and has laid the initial groundwork to suggest that examining racial identity in this population is 
important. This study is also unique in that it examines racial identity in the context of a pediatric 
chronic illness. For example, having SCD, which primarily affects African Americans in the 
U.S., may impact the development of a child’s racial identity. However, further research 
comparing racial identity in African American children with and without SCD may provide more 
information about the impact of SCD on racial identity. In addition, the environment in which 
children reported their racial identity is also important to consider. All children in this study were 
attending SCD clinics associated with a children’s hospital in an urban city in the southeastern 
U.S. Health care providers at both clinics were both Caucasian and African American. It is 
possible that the medical clinic setting and/or the race or ethnicity of the primary health care 
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provider may have impacted children’s report of racial identity. However, the racial identity 
findings from this study suggest that future research is needed to continue to investigate the 
relation between cultural factors and pain, quality of life, and coping, as well as other constructs, 
in pediatric patients with SCD. 
Limitations 
Despite the significant contributions of this study, caveats should be taken into account 
when interpreting results. First, the generalizability of the findings from this study is limited. 
Children in this study were attending a routine SCD-related medical visit; thus, these findings 
likely do not apply to children attending non-routine medical visits or those children 
experiencing acute pain crises. In fact, children participating in this study reported relatively low 
pain ratings. However, it is possible that different pain measures, such as pain diaries, may have 
been more sensitive. In addition, assessing pain on more than one occasion and following 
children for a specific period of time after their clinic visit may have revealed greater variability 
in pain ratings. 
Second, this study found a significant association between pain and quality of life; 
however, the results are correlational in nature and a causal relation cannot be determined. It may 
be possible that pain experiences lead to decreased quality of life but it also possible that quality 
of life may impact pain experiences. For example, decreased physical functioning may make it 
more likely that children with SCD experience increased acute and chronic pain. Examining 
potential causal relations between pain and quality of life via longitudinal studies would be 
important and might lead to additional avenues of intervention. In addition, due to the 
correlational nature of this study it is possible that there may be an unaccounted variable (e.g., 
response bias, method variance, etc.) that may be influencing the constructs examined.   
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Third, no parent report measures of pain, quality of life, and coping were utilized in this 
study, which is a limitation. Given that parents are responsible for most medical decisions, such 
as administering pain medications or taking a child with SCD to the emergency room during an 
acute pain episode, it is clinically important to include parent report in pediatric research. In 
addition, obtaining parent report could increase our understanding of parent perceptions of the 
impact of pediatric SCD, as well as the relation between child and parent report of pain, quality 
of life, and coping. Future studies focusing on pediatric SCD would benefit from using multiple 
informants (e.g., child, parent, health care providers, etc.). 
Fourth, to examine the main purpose of this study numerous hierarchical regression 
analyses were performed examining different types of coping, as well as examining different 
measures and domains of quality of life as the dependent variable. The number of analyses run in 
this study likely increased the chances of type I error, or finding a statistical difference when 
there is really not one. However, due to the paucity of research in the areas under investigation 
the number of analyses conducted seemed warranted.  
Future Directions 
To date, this is the first study to examine whether coping moderates the relation between 
pain and quality of life in children with SCD. Research focusing on the relation between pain 
and quality of life in children with SCD should continue to examine possible moderators 
impacting the relation. This study did not incorporate measures of spiritual or religious coping, 
which has been found to be important in African Americans with other types of chronic medical 
conditions (Christian & Barbarin, 2001). It would be important for future research to utilize these 
measures of coping in order to incorporate culturally sensitive measures of coping in research 
focusing on children with SCD. Future research is also needed to continue to identify effective 
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pain coping strategies so that interventions can be created to teach patients and their parents’ 
strategies that have empirical evidence for reducing disease-related pain and increasing quality of 
life. For example, results from this study suggest that emotion-focused avoidance coping is 
inversely associated with quality of life. Therefore, teaching coping strategies that reduce the 
reliance on this type of coping strategy may lead to improvements in quality of life. However, 
there is a need for future research to confirm and expand the findings from this study. 
Given that patients with SCD experience both acute and chronic pain, future research 
may benefit from examining the relation between quality of life and different types of pain 
separately. For example, it is possible that for children with SCD attending regularly scheduled 
clinic visits, chronic pain may be more likely to impact their quality of life, or everyday 
functioning. However, if a child is experiencing an acute pain episode and presenting to the 
emergency room it is likely that the impact of chronic pain is overshadowed by the impact of the 
acute pain episode. Assessing different types of pain longitudinally would also be valuable, as it 
could shed further light on the progressive nature of both acute and chronic pain in children with 
SCD. 
Similar to examining other types of coping and specific types of pain, future research 
should continue to examine specific domains of quality of life in children with SCD. It is likely 
that acute and chronic pain differentially impact domains of quality of life. For example, acute 
pain episodes may negatively impact physical functioning in children with SCD but may not 
significantly impact other areas, such as social functioning. It is not clear how acute and chronic 
pain in children with SCD may predict different domains of quality of life or whether specific 
coping strategies may moderate the relation. Continuing to examine additional ways to measure 
quality of life in children with SCD is also warranted. Results from this study suggest adequate 
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reliability and concurrent validity of the SCD-QoL, a SCD-specific measure of quality of life. 
Continuing to examine its psychometric properties, as well as its associations with other 
constructs is warranted. 
Future research should also continue to examine potential gender differences in pain, 
quality of life, and coping in children with SCD. This is especially important given findings from 
this study that there may be differential gender effects of coping types on quality of life. In 
addition, although age was not found to be associated with main variables in this study, 
continuing to examine developmental issues in this population is warranted, especially given the 
continued increase in life expectancy. Assessing pain, quality of life, and coping longitudinally 
in children with SCD would also be important. Longitudinal designs could provide further 
evidence for the causal relations between pain, quality of life, and coping and could provide 
important information about the progressive nature of SCD. Specifically, changes in pain, quality 
of life, and coping could be examined throughout the development of children with SCD, which 
could help physicians and psychologists better understand potential developmental issues 
patients experience, as well allow them to address developmental needs of children with SCD 
and their families. In addition, future research could examine the interaction between age and 
gender. For example, it would be interesting to investigate pain, quality of life, coping and racial 
identity in adolescent females. Adolescence would especially be an important age for further 
research due to the physical, cognitive, and emotional changes that occur during puberty. Also it 
may be likely that the pain experiences of adolescent females with SCD are qualitatively and 
quantitatively different compared to adolescent males with SCD due to menstruation and other 
physiological changes that accompany puberty.  
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Future studies focusing on children with SCD should continue to conduct culturally 
sensitive research and include cultural factors into their study designs (Clay et al., 2002; Kaslow 
et al., 1997; Kaslow et al., 2000); especially given findings from this study that indicate that 
racial identity is associated with quality of life and coping. Including racial identity and other 
cultural factors in future SCD-focused research can provide valuable information about this 
population (Bediako et al., 2007), which is an area that has largely been overlooked in both adult 
and pediatric SCD research. Further examining the racial experiences of adults and children with 
SCD would also be important. For example, there is little information about how perceived 
racism and prejudice may impact stress and pain-related symptoms in patients with SCD despite 
data suggesting that racism impacts the psychological and physical health of African Americans 
(Clark et al., 1999). It would also be interesting to examine whether the race or ethnicity of the 
health care provider may be related to cultural factors, as well as psychosocial functioning in 
children with SCD. In addition, researchers can begin to empirically identify cultural factors that 
may be important to include in culturally sensitive interventions (Clay et al., 2002; Kaslow et al., 
1997; Kaslow et al., 2000; Schwartz, Radcliffe, & Barakat, 2007). Another area of future 
research could also investigate how cultural variables, such as racial identity, may influence 
health beliefs and health behaviors, such as adherence, in children with SCD and their parents. 
Given that the cultural context of SCD is important to consider, future researchers should 
also consider the family context in children with SCD (Kazak, 2008). This can be accomplished 
by including parent report about child pain, coping, and quality of life, as well as focusing on 
what impact having a child with SCD places on the parental and family systems. In fact, one 
recent study found that coping and family functioning were positively associated (Mitchell, 
Lemanek, Palermo, Crosby, Nichols, & Powers, 2007). Continuing to examine family 
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functioning, as well as parenting stress, and the quality of the parent-child relationship would 
further our knowledge about the context of pediatric SCD. Studying cultural factors in families 
of children with SCD is also important, as racial identity is likely modeled by parents, making 
African American families a primary source of racial socialization for children (Radcliffe, 
Barakat, & Boyd, 2006). In addition, given that SCD primarily affects African Americans and 
runs in families it would be important to consider how cultural factors influence perceptions of 
SCD by patients, families, and health care providers.  
An additional area of future research is the inclusion of qualitative research methods in 
studies focusing on children with SCD. Qualitative research could further evaluate pain, quality 
of life, and coping, as well as allow for the qualitative examination of gender, cultural, and 
family factors. For example, research examining coping in other pediatric chronic illnesses has 
utilized vignettes where children and parents describe how they would handle specific generic 
and disease-specific problem situations (Quittner, Tolbert, Regoli, Orenstein, Hollingsworth, & 
Eigen, 1996). Answers provided by children and parents can then be qualitatively evaluated for 
content and effectiveness. However, quantitative measures of coping using this strategy have 
also been developed (Quittner et al., 1996) but have not been created or used in research focusing 
on children with SCD. To qualitatively examine family functioning, family narratives may be 
interesting to pursue in families with a child with SCD. Family narratives are a form of story 
telling which can facilitate children’s understanding and evaluation of their personal and family 
past and have been found to be related to sense of self in adolescents (Bohanek, Marin, Fivush, 
& Duke, 2006). Therefore, there are numerous qualitative methods that may be helpful in 
continuing to examine the psychosocial functioning of children with SCD and their families. 
74 
 In conclusion, this study examined pain, quality of life, and coping in children with SCD. 
In addition, developmental and cultural factors were examined. This study revealed that pain and 
emotion-focused avoidance coping were inversely associated with quality of life, but in general 
did not find that coping moderated the relation between pain and quality of life. Also, racial 
identity was found to be associated with both quality of life and coping. Results from this study 
highlight a number of future endeavors in the study of the psychosocial functioning of children 
with SCD. 
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Sickle Cell Disease (SCD) Background Information 
 
Questions about the Family 
1. Your Relation to Child:  ___Mother  ___Father  ___Grandparent  If other, describe: 
___________ 
 
2. Your Gender:  ___Male  ___Female 
 
3. Your Age:  ____ 
  
4. Your Ethnicity: ___Hispanic or Latino  ___Not Hispanic or Latino 
 
5. Your Race:  ___American Indian or Alaska Native  ___Asian  ___Black or African 
American  ___Native Hawaiian or Other Pacific Islander  ___White 
 
6. The highest education level you completed (Please write a number. For example, 8 = 
completed middle school, 10 = completed sophomore year of high school, 12 = graduated 
high school, 13 = completed freshman year of college, 16 = graduated college): ________ 
 
7. Please describe your occupation: 
_____________________________________________________ 
 
8. Your Marital Status: ___Single  ___Married/Partnered  ___Separated  ___Divorced  
___Widowed     If other, please describe: _____________ 
 
9. The highest education level your spouse/partner completed (Please write a number. For 
example, 10 = completed sophomore year of high school, 12 = graduated high school, 13 = 
completed freshman year of college, 16 = graduated college): ___ 
 
10. Please describe your spouse/partner’s occupation: 
_________________________________________ 
 
11. Please circle your approximate total family income per year: 
a. Up to $10,000    f.  $50,001 – 60,000 
b. $10,001 – 20,000    g. $60,001 – 70,000 
c. $20,001 – 30,000    h. $70,001 – 80,000 
d. $30,001 – 40,000    i.  $80,001 – 90,000 
e. $40,001 – 50,000    j.  $90,000 and above 
 
12. Do you have a chronic medical condition (e.g., asthma, SCD, diabetes, etc.)? YES NO 
If so, what kind(s) _________________________________ 
 
13. Does your spouse/partner have a chronic medical condition? YES  NO 
If so, what kind(s) _________________________________ 
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14. Have you been diagnosed with a psychological disorder (i.e., anxiety, depression, etc.)? 
YES NO 
If so, what _______________________________ 
 
15. Has your spouse/partner been diagnosed with a psychological disorder? YES NO 
If so, what _______________________________ 
 
Questions about the Child 
16. Child’s Gender:  ___Male  ___Female 
 
17. Child’s Age:  ____ yrs. ____ mos. 
 
18. Child’s Ethnicity: ___Hispanic or Latino  ___Not Hispanic or Latino 
 
19. Child’s Race: ___American Indian or Alaska Native  ___Asian  ___Black or African 
American  ___Native Hawaiian or Other Pacific Islander    ___White 
 
20. How many other children live in the home? ___  What are their ages? _____________ 
How many children in the home have SCD? ______ How many do not have SCD? ______ 
 
21. How many other adults live in the home? _____ What are their ages? ______________ 
 
22. What type of SCD does your child have? _____________________________________ 
 
23. Does your child have a chronic illness or medical condition besides SCD (e.g., asthma, 
diabetes)? 
YES NO   If so, what? _____________________________ 
 
24. Has your child been diagnosed with a psychological disorder (i.e., anxiety, depression, 
etc.)?  
YES NO   If so, what _______________________________ 
 
25. What medication(s) is your child prescribed? 
________________________________________________ 
 
26. Who is responsible for making sure your child takes their medication (i.e., you, child)? 
_______________ 
 
27. When was your child’s last SCD related clinic visit? __________________________ 
 
28. When was your child’s last SCD related hospitalization? _______________________ 
 
29. How many SCD related pain crises does your child usually experience in one year? 
________________ 
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30. What major complications has your child experienced related to SCD (i.e., strokes, etc.)? 
_________________________________________________________________________ 
 
31. How many days of school has your child missed due to SCD symptoms in the past school 
year? ________ 
 
32. How many days of work have you missed due to your child’s SCD symptoms in the past 
year? _________ 
 
33. Would you be willing to allow us to keep you and your child’s contact information for 
follow-up or future research projects?  YES  NO 
If YES, please provide your contact information below: 
 
Your Name: _________________________________ Phone #: __________________ 
 
Address: _____________________________________ 
 
   _____________________________________ 
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PedsQL 
Pediatric Pain Questionnaire 
Child Form (8-12 years of age) 
 
 
 
 
 
 
 
 
 
 
 
 
1. Put a mark on the line that best shows how you feel now. If you have no pain or 
hurt, you would put a mark at the end of the line by the happy face. If you have some 
pain or hurt, you would put a mark near the middle of the line. If you have a whole lot 
of pain or hurt, you would put a mark by the sad face. 
☺             
            Not hurting                 Hurting a whole lot 
          No discomfort               Very uncomfortable 
               No pain                       Severe Pain 
 
2. Put a mark on the line that best shows what was the worst pain you had this 
week. If you had no pain or hurt this week, you would put a mark at the end of the 
line by the happy face. If you had some pain or hurt, you would put a mark by the 
middle of the line. If the worse pain you had was a whole lot of pain, you would put a 
mark by the sad face. 
 ☺           
            Not hurting        Hurting a whole lot 
          No discomfort      Very uncomfortable 
               No pain         Severe Pain 
 
Name:             
 
Date:        Record Number:    
  
What words would you use to describe your pain or hurt? 
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Pick the colors that mean No hurt, A little hurt, More hurt, and A lot of hurt to you 
and color in the boxes. Now, using these colors, color in the body to show how you feel. 
Where you have no hurt, use the No hurt color to color in your body. If you have hurt or 
pain, use the color that tells how much hurt you have. 
 
  No pain    Mild pain  Moderate pain Severe pain 
  No hurt  A little hurt     More hurt  A lot of hurt 
 
 
 
 
 
 
             
 
         
 Front   Back 
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PedsQL 
Pediatric Pain Questionnaire 
Teen Form (13-18 years of age) 
 
 
 
 
 
 
 
 
 
 
1. Put a mark on the line that best shows how you feel now. If you have no pain or 
hurt, you would put a mark at the end of the line by the happy face. If you have some 
pain or hurt, you would put a mark near the middle of the line. If you have a whole lot 
of pain or hurt, you would put a mark by the sad face. 
 ☺          
            Not hurting                   Hurting a whole lot 
          No discomfort               Very uncomfortable 
               No pain          Severe Pain 
 
2. Put a mark on the line that best shows what was the worst pain you had this 
week. If you had no pain or hurt this week, you would put a mark at the end of the 
line by the happy face. If you had some pain or hurt, you would put a mark by the 
middle of the line. If the worse pain you had was a whole lot of pain, you would put a 
mark by the sad face. 
 ☺          
            Not hurting        Hurting a whole lot 
          No discomfort               Very uncomfortable 
               No pain          Severe Pain 
 
 
Name:             
 
Date:        Record Number:    
  
What words would you use to describe your pain or hurt? 
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Please mark an X on the exact place where you are having pain now. If there is more 
than one painful place, mark them ‘1’, ‘2’, ‘3’, etc., starting with the most painful place as 
‘1’. 
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Sickle Cell Pain 
 
 
 
1. What was the general or normal pain you had this week?  
☺           
        No hurting         Hurting a whole lot 
      No discomfort         Very uncomfortable 
           No pain                       Severe Pain 
 
 
2. Compared to other kids with sickle cell, my pain is usually: 
☺          
  Better              Worse 
 
 
3. Compared to other kids without sickle cell, my pain is usually: 
☺          
  Better             Worse 
 
 
 
4. About how many pain crises do you usually have in a month? __________ 
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APPENDIX C 
Pediatric Quality of Life Inventory (PedsQL) 
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PedsQL ™ 
Pediatric Quality of Life
  
Inventory
 
 
Version 4.0 
 
 
CHILD  REPORT (ages 8-12) 
 
 
 
 
DIRECTIONS 
 
     On the following page is a list of things that might be a problem for you. 
     Please tell us how much of a problem each one has been for you 
     during the past  ONE  month by circling: 
 
0 if it is never a problem  
1 if it is almost never a problem  
2 if it is sometimes a problem 
3 if it is often a problem 
4 if it is almost always a problem 
 
     There are no right or wrong answers.   
     If you do not understand a question, please ask for help. 
 
 
 
 
 
 
ID# _____________________ 
 
Date:____________________ 
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In the past ONE month, how much of a problem has this been for you … 
     
About My Health and Activities (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  It is hard for me to walk more than one block 0 1 2 3 4 
2.  It is hard for me to run 0 1 2 3 4 
3.  It is hard for me to do sports activity or exercise 0 1 2 3 4 
4.  It is hard for me to lift something heavy 0 1 2 3 4 
5.  It is hard for me to take a bath or shower by myself  0 1 2 3 4 
6.  It is hard for me to do chores around the house  0 1 2 3 4 
7.  I hurt or ache  0 1 2 3 4 
8.  I have low energy 0 1 2 3 4 
   
About My Feelings (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   I feel afraid or scared 0 1 2 3 4 
2.   I feel sad or blue 0 1 2 3 4 
3.   I feel angry 0 1 2 3 4 
4.   I have trouble sleeping 0 1 2 3 4 
5.   I worry about what will happen to me 0 1 2 3 4 
 
How I Get Along with Others (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  I have trouble getting along with other kids 0 1 2 3 4 
2.  Other kids do not want to be my friend  0 1 2 3 4 
3.  Other kids tease me  0 1 2 3 4 
4.  I cannot do things that other kids my age can do 0 1 2 3 4 
5.  It is hard to keep up when I play with other kids 0 1 2 3 4 
  
About School (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   It is hard to pay attention in class 0 1 2 3 4 
2.   I forget things 0 1 2 3 4 
3.   I have trouble keeping up with my schoolwork 0 1 2 3 4 
4.   I miss school because of not feeling well  0 1 2 3 4 
5.   I miss school to go to the doctor or hospital 0 1 2 3 4 
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PedsQL ™  
Pediatric Quality of Life
  
Inventory
 
 
Version 4.0 
 
 
TEEN REPORT (ages 13-18) 
 
 
 
 
DIRECTIONS 
 
     On the following page is a list of things that might be a problem for you. 
     Please tell us how much of a problem each one has been for you 
     during the past  ONE  month by circling: 
 
0 if it is never a problem  
1 if it is almost never a problem  
2 if it is sometimes a problem 
3 if it is often a problem 
4 if it is almost always a problem 
 
     There are no right or wrong answers.   
     If you do not understand a question, please ask for help. 
 
 
 
 
 
ID# _____________________ 
 
Date:____________________ 
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In the past ONE month, how much of a problem has this been for you … 
 
About My Health and Activities (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  It is hard for me to walk more than one block 0 1 2 3 4 
2.  It is hard for me to run 0 1 2 3 4 
3.  It is hard for me to do sports activity or exercise  0 1 2 3 4 
4.  It is hard for me to lift something heavy 0 1 2 3 4 
5.  It is hard for me to take a bath or shower by 
myself 
0 1 2 3 4 
6.  It is hard for me to do chores around the house  0 1 2 3 4 
7.  I hurt or ache  0 1 2 3 4 
8.  I have low energy 0 1 2 3 4 
 
About My Feelings (PROBLEMS WITH…) Never  Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   I feel afraid or scared 0 1 2 3 4 
2.   I feel sad or blue 0 1 2 3 4 
3.   I feel angry 0 1 2 3 4 
4.   I have trouble sleeping 0 1 2 3 4 
5.   I worry about what will happen to me 0 1 2 3 4 
 
How I Get Along with Others (PROBLEMS WITH) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  I have trouble getting along with other 
teens 
0 1 2 3 4 
2.  Other teens do not want to be my friend  0 1 2 3 4 
3.  Other teens tease me  0 1 2 3 4 
4.  I cannot do things that other teens my age 
can do 
0 1 2 3 4 
5.  It is hard to keep up with my peers 0 1 2 3 4 
    
About School (PROBLEMS WITH…) Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   It is hard to pay attention in class 0 1 2 3 4 
2.   I forget things 0 1 2 3 4 
3.   I have trouble keeping up with my schoolwork 0 1 2 3 4 
4.   I miss school because of not feeling well  0 1 2 3 4 
5.   I miss school to go to the doctor or hospital 0 1 2 3 4 
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Sickle Cell Disease Quality of Life (SCD-QoL) 
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Sickle Cell Disease Quality of Life (SCD-QoL) 
 
These questions are for children like you who have sickle cell disease. Your 
answers will help us understand what this disease is like and how your treatments 
help you. Answering these questions will help you and others like you in the 
future. 
 
There are no right or wrong answers! If you are not sure how to answer, choose the 
response that seems closest to you.  
 
During the past two weeks: 
 
 Always Often Some-
times 
Never 
 
    
1. I felt a sharp pain ……………………………     
 
    
2. I felt uncomfortable …………………………     
 
    
3. I had trouble listening in class ………...........        
 
    
4. I felt out of control …………………………  ⁭ ⁭ ⁭ 
 
    
5. I had difficulty controlling my pain ............... ⁭ ⁭ ⁭ ⁭ 
 
    
6. I was able to engage in normal activities with 
friends ……………………………………… 
 
⁭ 
 
⁭ 
 
⁭ 
 
⁭ 
 
    
7. I took all of my medication ………………… ⁭ ⁭ ⁭ ⁭ 
 
    
8. I felt tired …………………………………… ⁭ ⁭ ⁭ ⁭ 
 
    
9. I had low energy ……………………............. ⁭ ⁭ ⁭ ⁭ 
 
    
10. I could not play when I wanted to ………...... ⁭ ⁭ ⁭ ⁭ 
 
    
11. I was able to run and jump …………………. ⁭ ⁭ ⁭ ⁭ 
 
    
12. I felt stressed ……………………………….. ⁭ ⁭ ⁭ ⁭ 
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 Always Often Some-
times 
Never 
 
    
13. I spent time with friends …………………… ⁭ ⁭  ⁭ 
 
    
14. I felt sad ……………………………………. ⁭ ⁭  ⁭ 
 
    
15. I felt a dull, soft pain ……………………….. ⁭ ⁭    ⁭ ⁭ 
 
    
16. I felt worried ……………………………….. ⁭ ⁭  ⁭ 
 
    
17. I felt mad …………………………………... ⁭ ⁭   ⁭ 
 
    
18. I felt good about myself ……………............ ⁭ ⁭  ⁭ 
 
    
19. I had trouble falling asleep ………………… ⁭ ⁭  ⁭ 
 
    
20. I was treated differently by my teachers ….. ⁭ ⁭  ⁭ 
 
    
21. I felt happy ………………………………… ⁭ ⁭  ⁭ 
 
    
22. I was teased by other kids …………………. ⁭ ⁭  ⁭ 
 
    
23. I missed school …………………………….. ⁭ ⁭  ⁭ 
 
    
24. I thought I was physically different from 
others my age …………………………….... 
 
⁭ 
 
⁭ 
 
 
 
⁭ 
 
    
25. I couldn’t keep up with my school work …... ⁭ ⁭  ⁭ 
 
    
26. I felt pressure from my friends …………….. ⁭ ⁭  ⁭ 
 
    
27. I was sent home early or missed school     
because I was sick or in pain……………….. 
 
⁭ 
 
⁭ 
 
 
 
⁭ 
 
    
28. I was able to participate in sports I like ......... ⁭ ⁭  ⁭ 
 
 
 
THANK YOU FOR YOUR TIME!! 
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APPENDIX F 
Multidimensional Inventory of Black Identity (MIBI) 
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Child Multidimensional Inventory of Black Identity (MIBI) 
 
Please indicate below how strongly you disagree or agree with the statements by circling 
the number that applies most to you.  
 
1.    Overall, being Black has very little to do with how I 
feel about myself. 
1 2 3 4 5 6 7 
 
       
2.    I feel good about Black people. 1 2 3 4 5 6 7 
        
3.    Overall, Blacks are considered good by others. 1 2 3 4 5 6 7 
        
4.     In general, being Black is an important part of my 
self  image (e.g., how I see myself). 
1 2 3 4 5 6 7 
        
5.    I am happy that I am Black. 1 2 3 4 5 6 7 
        
6.    I feel that Blacks have made major accomplishments 
and advancements (e.g., successes, achievements). 
1 2 3 4 5 6 7 
        
7.    My destiny (e.g., fate) is tied to the destiny of other 
Black people. 
1 2 3 4 5 6 7 
        
8.    Being Black is unimportant to my sense of what kind 
of person I am. 
1 2 3 4 5 6 7 
        
9.    In general, others respect Black people. 1 2 3 4 5 6 7 
        
10.  Most people consider Blacks, on average to be more 
ineffective (e.g., unproductive) than other racial groups.  
1 2 3 4 5 6 7 
        
11.  I have a strong sense of belonging (e.g., fitting in) 
with Black people. 
1 2 3 4 5 6 7 
        
12.   I often regret (e.g., feel sorry) that I am Black. 1 2 3 4 5 6 7 
        
13.   I have a strong attachment to other Black people.  1 2 3 4 5 6 7 
        
14.   Being Black is an important reflection of who I am. 1 2 3 4 5 6 7 
        
15.   Being Black is not a major factor in my social 
relationships. 
1 2 3 4 5 6 7 
        
16.   Blacks are not respected by the broader society. 1 2 3 4 5 6 7 
        
17. In general, other groups view Blacks in a positive 
manner. 
1 2 3 4 5 6 7 
        
18.   I am proud to be Black. 1 2 3 4 5 6 7 
        
19.   I feel that the Black community has made valuable 
contributions to this society. 
1 2 3 4 5 6 7 
        
20. Society views Black people as an asset (e.g., 
benefit). 
1 2 3 4 5 6 7 
Strongly 
Agree Neutral 
Strongly 
Disagree 
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Table 19 
Gender Specific Regression Analyses of Pain and Coping Types on Generic Overall Quality of 
Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.021 0.021 0.879 
     Site  -0.090    
Step 2  0.286 0.265 7.226** 
     Total Pain -0.557***    
     Approach Coping -0.211    
Step 3  0.296 0.011 0.573 
     Total Pain x Approach Coping -0.136    
Problem-Focused Avoidance Coping (N = 45) 
Step 1  0.035 0.035 1.619 
     Site -0.097    
Step 2  0.298 0.263 7.860*** 
     Total Pain -0.458***    
     Problem-Focused Avoidance (PFA)  0.112    
Step 3  0.311 0.013 0.791 
     Total Pain x PFA Coping -0.130    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1  0.048 0.048   2.240 
     Site -0.181    
Step 2  0.513 0.464 20.023*** 
     Total Pain -0.261†    
     Emotion-Focused Avoidance (EFA) -0.534***    
Step 3  0.513 0.000   0.000 
     Total Pain x EFA Coping  0.000    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 43)     
Step 1  0.065 0.065 2.934† 
     Site  -0.286*    
Step 2  0.306 0.240 6.918** 
     Total Pain -0.522**    
     Approach Coping  0.025    
Step 3  0.307 0.001 0.064 
     Total Pain x Approach Coping  0.042    
Problem-Focused Avoidance Coping (N = 48) 
Step 1  0.102 0.102 5.310* 
     Site -0.329*    
Step 2  0.330 0.229 7.690*** 
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     Total Pain -0.508***    
     Problem-Focused Avoidance (PFA)  0.025    
Step 3  0.340 0.009 0.621 
     Total Pain x PFA Coping  0.100    
Emotion-Focused Avoidance Coping (N = 47) 
Step 1  0.083 0.083 4.170* 
     Site -0.286*    
Step 2  0.354 0.271 9.239*** 
     Total Pain -0.432***    
     Emotion-Focused Avoidance (EFA) -0.244†    
Step 3  0.355 0.001 0.017 
     Total Pain x EFA Coping -0.017    
Note. Dependent variable = PedsQL Total Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 20 
Gender Specific Regression Analyses of Pain and Coping Types on Generic Physical Quality of 
Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.038 0.038 1.621 
     Site -0.137    
Step 2  0.333 0.295 8.614*** 
     Total Pain -0.586***    
     Approach Coping -0.221    
Step 3  0.344 0.011 0.631 
     Total Pain x Approach Coping -0.138    
Problem-Focused Avoidance Coping (N = 45) 
Step 1  0.069 0.069 3.264† 
     Site -0.179    
Step 2  0.342 0.273 8.772*** 
     Total Pain -0.479***    
     Problem-Focused Avoidance (PFA)  0.045    
Step 3  0.362 0.020 1.300 
     Total Pain x PFA Coping -0.161    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1  0.096 0.096   4.649* 
     Site -0.255*    
Step 2  0.400 0.304 10.632*** 
     Total Pain -0.373*    
     Emotion-Focused Avoidance (EFA) -0.258†    
Step 3  0.401 0.001 0.078 
     Total Pain x EFA Coping -0.043    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 44) 
Step 1  0.042 0.042 1.878 
     Site -0.223    
Step 2  0.250 0.208 5.685** 
     Total Pain -0.409*    
     Approach Coping  0.026    
Step 3  0.255 0.005 0.288 
     Total Pain x Approach Coping -0.093    
Problem-Focused Avoidance Coping (N = 49) 
Step 1  0.072 0.072 3.719† 
     Site -0.290*    
Step 2  0.269 0.197 6.191** 
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     Total Pain -0.447**    
     Problem-Focused Avoidance (PFA)  0.084    
Step 3  0.270 0.001 0.060 
     Total Pain x PFA Coping -0.032    
Emotion-Focused Avoidance Coping (N = 48) 
Step 1  0.042 0.042 2.079 
     Site -0.220    
Step 2  0.215 0.172 4.939* 
     Total Pain -0.386**    
     Emotion-Focused Avoidance (EFA) -0.161    
Step 3  0.218 0.003 0.174 
     Total Pain x EFA Coping  0.061    
Note. Dependent variable is PedsQL Physical Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 21 
Gender Specific Regression Analyses of Pain and Coping Styles on Generic Emotional Quality 
of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.007 0.007 0.270 
     Site -0.045    
Step 2  0.149 0.143 3.276* 
     Total Pain -0.438*    
     Approach Coping -0.220    
Step 3  0.170 0.021 0.939 
     Total Pain x Approach Coping -0.189    
Problem-Focused Avoidance Coping (N = 46) 
Step 1   0.002 0.002 0.106 
     Site  0.019    
Step 2  0.125 0.122 3.004† 
     Total Pain -0.299†    
     Problem-Focused Avoidance (PFA)  0.119    
Step 3  0.129 0.005 0.219 
     Total Pain x PFA Coping -0.076    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1  0.004 0.004   0.193 
     Site -0.054    
Step 2  0.460 0.455 17.694*** 
     Total Pain -0.059    
     Emotion-Focused Avoidance (EFA) -0.652***    
Step 3  0.460 0.000 0.014 
     Total Pain x EFA Coping  0.017    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 46) 
Step 1  0.060 0.060 2.895† 
     Site -0.233†    
Step 2  0.141 0.137 3.664* 
     Total Pain -0.508**    
     Approach Coping -0.122    
Step 3  0.264 0.067 3.799† 
     Total Pain x Approach Coping 0.320†    
Problem-Focused Avoidance Coping (N = 51) 
Step 1   0.073 0.073 3.920† 
     Site -0.316*    
Step 2  0.241 0.168 5.307** 
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     Total Pain -0.464***    
     Problem-Focused Avoidance (PFA)  0.213    
Step 3  0.278 0.037 2.436 
     Total Pain x PFA Coping  0.200    
Emotion-Focused Avoidance Coping (N = 50) 
Step 1  0.063 0.063 3.312† 
     Site -0.193    
Step 2  0.348 0.285 10.266*** 
     Total Pain -0.326**    
     Emotion-Focused Avoidance (EFA) -0.342**    
Step 3  0.362 0.014 0.976 
     Total Pain x EFA Coping -0.126    
Note. Dependent variable is PedsQL Emotion Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001 
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Table 22 
Gender Specific Regression Analyses of Pain and Coping Styles on Generic Social Quality of 
Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.007 0.007 0.298 
     Site -0.035    
Step 2  0.157 0.150 3.472* 
     Total Pain -0.374*    
     Approach Coping -0.109    
Step 3  0.157 0.000 0.006 
     Total Pain x Approach Coping  0.015    
Problem-Focused Avoidance Coping (N = 46) 
Step 1  0.008 0.008 0.349 
     Site -0.021    
Step 2  0.155 0.147 3.754* 
     Total Pain -0.332*    
     Problem-Focused Avoidance (PFA)  0.047    
Step 3  0.177 0.022 1.123 
     Total Pain x PFA Coping -0.168    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1  0.019 0.019   0.864 
     Site -0.115    
Step 2  0.377 0.357 12.044*** 
     Total Pain -0.161    
     Emotion-Focused Avoidance (EFA) -0.523***    
Step 3  0.377 0.000   0.029 
     Total Pain x EFA Coping  0.027    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 47)     
Step 1  0.038 0.038 1.796 
     Site -0.198    
Step 2  0.151 0.114 2.950† 
     Total Pain -0.350*    
     Approach Coping  0.160    
Step 3  0.151 0.000 0.000 
     Total Pain x Approach Coping  0.002    
Problem-Focused Avoidance Coping (N = 52) 
Step 1  0.062 0.062 3.368† 
     Site -0.210    
Step 2  0.145 0.083 2.390 
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     Total Pain -0.306*    
     Problem-Focused Avoidance (PFA) -0.059    
Step 2  0.177 0.032 1.857 
     Total Pain x PFA Coping  0.185    
Emotion-Focused Avoidance Coping (N = 51) 
Step 1  0.071 0.071 3.796† 
     Site -0.245†    
Step 2  0.262 0.191 6.209** 
     Total Pain -0.296*    
     Emotion-Focused Avoidance (EFA) -0.348*    
Step 3  0.274 0.012 0.786 
     Total Pain x EFA Coping  0.119    
Note. Dependent variable is PedsQL Social Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 23 
Gender Specific Regression Analyses of Pain and Coping Styles on Generic School Quality of 
Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.009 0.009 0.356 
     Site -0.055    
Step 2  0.169 0.160 3.760* 
     Total Pain -0.455**    
     Approach Coping -0.142    
Step 3  0.178 0.009 0.401 
     Total Pain x Approach Coping -0.123    
Problem-Focused Avoidance Coping (N = 46) 
Step 1  0.019 0.019 0.878 
     Site -0.052    
Step 2  0.208 0.189 5.136** 
     Total Pain -0.377*    
     Problem-Focused Avoidance (PFA)  0.200    
Step 3  0.208 0.000 0.009 
     Total Pain x PFA Coping -0.014    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1   0.024 0.024   1.076 
     Site  -0.127    
Step 2  0.387 0.363 12.417*** 
     Total Pain -0.193    
     Emotion-Focused Avoidance (EFA) -0.506***    
Step 3  0.387 0.000   0.026 
     Total Pain x EFA Coping  0.025    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 47)     
Step 1  0.050 0.050 2.413 
     Site -0.218    
Step 2  0.171 0.121 3.222* 
     Total Pain -0.325†    
     Approach Coping -0.067    
Step 3  0.171 0.000 0.001 
     Total Pain x Approach Coping  0.005    
Problem-Focused Avoidance Coping (N = 52) 
Step 1  0.073 0.073 3.999† 
     Site -0.195    
Step 2  0.230 0.157 5.000* 
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     Total Pain -0.310*    
     Problem-Focused Avoidance (PFA) -0.188    
Step 3  0.231 0.001 0.066 
     Total Pain x PFA Coping -0.034    
Emotion-Focused Avoidance Coping (N = 51) 
Step 1   0.069 0.069 3.707† 
     Site  -0.259†    
Step 2  0.180 0.111 3.234* 
     Total Pain -0.322*    
     Emotion-Focused Avoidance (EFA)  0.017    
Step 3  0.186 0.006 0.366 
     Total Pain x EFA Coping -0.086    
Note. Dependent variable is PedsQL School Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 24 
Gender Specific Regression Analyses of Pain and Coping Styles on Disease-specific Overall 
Quality of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 41) 
Step 1  0.035 0.035   1.462 
     Site -0.114    
Step 2  0.398 0.363 11.450*** 
     Total Pain -0.617***    
     Approach Coping -0.283†    
Step 3  0.405 0.007   0.426 
     Total Pain x Approach Coping -0.109    
Problem-Focused Avoidance Coping (N = 44) 
Step 1  0.029 0.029 1.292 
     Site -0.106    
Step 2  0.314 0.285 8.523*** 
     Total Pain -0.506***    
      Problem-Focused Avoidance (PFA)  0.039    
Step 3  0.323 0.009 0.502 
     Total Pain x PFA Coping -0.105    
Emotion-Focused Avoidance Coping (N = 42) 
Step 1   0.034 0.034   1.456 
     Site  -0.147    
Step 2  0.552 0.517 22.514*** 
     Total Pain -0.249    
     Emotion-Focused Avoidance (EFA) -0.554***    
Step 3  0.555 0.003   0.253 
     Total Pain x EFA Coping -0.072    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 44) 
Step 1  0.050 0.050 2.257 
     Site -0.226    
Step 2  0.193 0.143 3.646* 
     Total Pain -0.433*    
     Approach Coping  0.061    
Step 3  0.199 0.006 0.294 
     Total Pain x Approach Coping  0.090    
Problem-Focused Avoidance Coping (N = 49) 
Step 1  0.069 0.069 3.568† 
     Site -0.289*    
Step 2  0.244 0.175 5.336** 
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     Total Pain -0.416**    
     Problem-Focused Avoidance (PFA)  0.168    
Step 3  0.245 0.000 0.005 
     Total Pain x PFA Coping -0.010    
Emotion-Focused Avoidance Coping (N = 48) 
Step 1   0.060 0.060 3.003† 
     Site  -0.226†    
Step 2  0.310 0.250 8.142*** 
     Total Pain -0.353*    
     Emotion-Focused Avoidance (EFA) -0.389**    
Step 3  0.330 0.30 1.306 
     Total Pain x EFA Coping  0.159    
Note. Dependent variable is SCD-QoL Total Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 25 
Gender Specific Regression Analyses of Pain and Coping Types on Disease-specific Physical 
Quality of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 41) 
Step 1  0.030 0.030   1.256 
     Site -0.100    
Step 2  0.463 0.433 15.306*** 
     Total Pain -0.682***    
     Approach Coping -0.253†    
Step 3  0.472 0.009   0.619 
     Total Pain x Approach Coping -0.124    
Problem-Focused Avoidance Coping (N = 44) 
Step 1  0.026 0.026   1.135 
     Site -0.102    
Step 2  0.390 0.362 12.239*** 
     Total Pain -0.607***    
     Problem-Focused Avoidance (PFA)  0.022    
Step 3  0.390 0.000   0.008 
     Total Pain x PFA Coping  0.013    
Emotion-Focused Avoidance Coping (N = 42) 
Step 1   0.030 0.030   1.258 
     Site  -0.121    
Step 2  0.546 0.516 22.195*** 
     Total Pain -0.336*    
     Emotion-Focused Avoidance (EFA) -0.454***    
Step 3  0.555 0.009   0.746 
     Total Pain x EFA Coping -0.123    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 46) 
Step 1  0.032 0.032 1.501 
     Site -0.149    
Step 2  0.237 0.205 5.763** 
     Total Pain -0.425**    
     Approach Coping -0.142    
Step 3  0.239 0.002 0.098 
     Total Pain x Approach Coping  0.049    
Problem-Focused Avoidance Coping (N = 51) 
Step 1  0.053 0.053 2.808† 
     Site -0.240†    
Step 2  0.294 0.240 8.166*** 
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     Total Pain -0.476***    
     Problem-Focused Avoidance (PFA)  0.176    
Step 3  0.304 0.011 0.714 
     Total Pain x PFA Coping -0.106    
Emotion-Focused Avoidance Coping (N = 50) 
Step 1   0.038 0.038 1.954 
     Site  -0.169    
Step 2  0.313 0.274 9.382*** 
     Total Pain -0.419**    
     Emotion-Focused Avoidance (EFA) -0.372**    
Step 3  0.343 0.030 2.128 
     Total Pain x EFA Coping  0.194    
Note. Dependent variable is SCD-QoL Physical Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p 
< 0.001. 
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Table 26 
Gender Specific Regression Analyses of Pain and Coping Styles on Disease-specific Emotional 
Quality of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.027 0.027 1.124 
     Site -0.088    
Step 2  0.342 0.315 9.333*** 
     Total Pain -0.523***    
     Approach Coping -0.119    
Step 3  0.345 0.003 0.199 
     Total Pain x Approach Coping  0.077    
Problem-Focused Avoidance Coping (N = 46) 
Step 1  0.009 0.009 0.423 
     Site -0.022    
Step 2  0.227 0.218 6.060** 
     Total Pain -0.418**    
     Problem-Focused Avoidance (PFA)  0.012    
Step 3  0.259 0.032 1.819 
     Total Pain x PFA Coping -0.202    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1   0.009 0.009   0.421 
     Site  -0.063    
Step 2  0.483 0.474 19.245 
     Total Pain -0.167    
     Emotion-Focused Avoidance (EFA) -0.572***    
Step 3  0.490 0.007   0.529 
     Total Pain x EFA Coping -0.104    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 47) 
Step 1  0.049 0.049 2.394 
     Site -0.211    
Step 2  0.106 0.056 1.384 
     Total Pain -0.416*    
     Approach Coping  0.016    
Step 3  0.174 0.068 3.541† 
     Total Pain x Approach Coping 0.325†    
Problem-Focused Avoidance Coping (N = 52) 
Step 1  0.049 0.049 2.627 
     Site -0.275†    
Step 2  0.141 0.092 2.627† 
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     Total Pain -0.304*    
     Problem-Focused Avoidance (PFA)  0.223    
Step 3  0.149 0.008 0.449 
     Total Pain x PFA Coping  0.092    
Emotion-Focused Avoidance Coping (N = 51) 
Step 1   0.051 0.051 2.698 
     Site  -0.182    
Step 2  0.240 0.189 5.965** 
     Total Pain -0.221†    
     Emotion-Focused Avoidance (EFA) -0.358*    
Step 3  0.240 0.000 0.000 
     Total Pain x EFA Coping  0.001    
Note. Dependent variable is SCD-QoL Emotion Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p 
< 0.001 
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Table 27 
Gender Specific Regression Analyses of Pain and Coping Styles on Disease-specific Social 
Quality of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.015 0.015 0.613 
     Site -0.098    
Step 2  0.090 0.076 1.622 
     Total Pain -0.337†    
     Approach Coping -0.262    
Step 3  0.123 0.032 1.391 
     Total Pain x Approach Coping -0.236    
Problem-Focused Avoidance Coping (N = 46) 
Step 1  0.012 0.012 0.529 
     Site -0.047    
Step 2  0.095 0.083 1.981 
     Total Pain -0.203    
     Problem-Focused Avoidance (PFA)  0.082    
Step 3  0.122 0.027 1.300 
     Total Pain x PFA Coping -0.186    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1   0.028 0.028 1.264 
     Site  -0.153    
Step 2  0.192 0.164 4.275* 
     Total Pain -0.115    
     Emotion-Focused Avoidance (EFA) -0.361*    
Step 3  0.194 0.002 0.098 
     Total Pain x EFA Coping  0.056    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 46) 
Step 1  0.056 0.056 2.681 
     Site -0.252†    
Step 2  0.122 0.066 1.613 
     Total Pain -0.262    
     Approach Coping  0.197    
Step 3  0.124 0.002 0.100 
     Total Pain x Approach Coping  0.057    
Problem-Focused Avoidance Coping (N = 51) 
Step 1  0.077 0.077 4.147* 
     Site -0.350*    
Step 2  0.150 0.074 2.082 
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     Total Pain -0.254†    
     Problem-Focused Avoidance (PFA)  0.265†    
Step 3  0.175 0.025 1.398 
     Total Pain x PFA Coping  0.162    
Emotion-Focused Avoidance Coping (N = 50) 
Step 1   0.073 0.073 3.873† 
     Site  -0.233†    
Step 2  0.285 0.212 6.973** 
     Total Pain -0.111    
     Emotion-Focused Avoidance (EFA) -0.501***    
Step 3  0.311 0.026 1.712 
     Total Pain x EFA Coping  0.173    
Note. Dependent variable is SCD-QoL Social Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
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Table 28 
Gender Specific Regression Analyses of Pain and Coping Styles on Disease-specific School 
Quality of Life 
Males     
Variables β R2 R2 Change F Change 
Approach Coping (N = 42) 
Step 1  0.046 0.046 1.977 
     Site -0.152    
Step 2  0.284 0.238 6.472** 
     Total Pain -0.454**    
     Approach Coping -0.416*    
Step 3  0.301 0.017 0.921 
     Total Pain x Approach Coping -0.171    
Problem-Focused Avoidance Coping (N = 46) 
Step 1  0.046 0.046 2.185 
     Site -0.158    
Step 2  0.163 0.117 2.995† 
     Total Pain -0.329*    
     Problem-Focused Avoidance (PFA)  0.087    
Step 3  0.163 0.000 0.000 
     Total Pain x PFA Coping -0.019    
Emotion-Focused Avoidance Coping (N = 45) 
Step 1   0.051 0.051 2.384 
     Site  -0.205    
Step 2  0.338 0.286 9.075*** 
     Total Pain -0.135    
     Emotion-Focused Avoidance (EFA) -0.466**    
Step 3  0.338 0.000 0.000 
     Total Pain x EFA Coping  0.000    
Females     
Variables β R2 R2 Change F Change 
Approach Coping (N = 45) 
Step 1  0.079 0.079 3.758† 
     Site -0.305*    
Step 2  0.292 0.214 6.338** 
     Total Pain -0.514**    
     Approach Coping  0.297*    
Step 3  0.303 0.010 0.607 
     Total Pain x Approach Coping  0.128    
Problem-Focused Avoidance Coping (N = 50) 
Step 1  0.094 0.094 5.061* 
     Site -0.293*    
Step 2  0.215 0.121 3.628* 
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     Total Pain -0.368*    
     Problem-Focused Avoidance (PFA) -0.001    
Step 3  0.222 0.007 0.441 
     Total Pain x PFA Coping  0.090    
Emotion-Focused Avoidance Coping (N = 49) 
Step 1   0.080 0.080 4.158* 
     Site  -0.275*    
Step 2  0.199 0.119 3.414* 
     Total Pain -0.283*    
     Emotion-Focused Avoidance (EFA) -0.184    
Step 3  0.199 0.000 0.013 
     Total Pain x EFA Coping  0.017    
Note. Dependent variable is SCD-QoL School Score. † p < 0.10, * p < 0.05, ** p < 0.01, *** p < 
0.001. 
 
